WO2007114125A1 - Process for production of hydroxylated adamantane using microorganism - Google Patents

Process for production of hydroxylated adamantane using microorganism Download PDF

Info

Publication number
WO2007114125A1
WO2007114125A1 PCT/JP2007/056542 JP2007056542W WO2007114125A1 WO 2007114125 A1 WO2007114125 A1 WO 2007114125A1 JP 2007056542 W JP2007056542 W JP 2007056542W WO 2007114125 A1 WO2007114125 A1 WO 2007114125A1
Authority
WO
WIPO (PCT)
Prior art keywords
adamantyl
monohydroxy
phthalimide
rhizoctonia
group
Prior art date
Application number
PCT/JP2007/056542
Other languages
French (fr)
Japanese (ja)
Inventor
Yuuichi Mitsuda
Kazuyuki Minagawa
Tomoyuki Ogawa
Original Assignee
Shionogi & Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co., Ltd. filed Critical Shionogi & Co., Ltd.
Priority to JP2008508544A priority Critical patent/JPWO2007114125A1/en
Publication of WO2007114125A1 publication Critical patent/WO2007114125A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi

Definitions

  • the present invention relates to a method for producing an amino protected form of monohydroxy-12-adamantanamine (eg, N- (monohydroxy-2-adamantyl) phthalimide derivative) using a microorganism.
  • monohydroxy-2-adamantanamine amine protector is a raw material of monohydroxy-2-adamantanamine, and monohydroxy-2-adamantanamine is useful as an intermediate for pharmaceuticals.
  • a method for producing an adamantane derivative hydroxide using a microorganism has been known for some time. For example, by using biotransformation of Beauveria sulfurescens, it is possible to produce adamantamine hydroxyammonium salt protected with benzylamide (Non-patent Document 1). In addition, it has been reported that an adamantane derivative protected with phthalimide can also produce a dihydroxy form by in vivo conversion of Sporotrichum sulfurescens (Non-patent Document 2).
  • Patent Document 1 JP 2006-63061
  • Patent Document 2 International Publication No. WO04Z056744 Pamphlet
  • Non-Patent Document 1 “Journal of Organic Chemistry”, 1992, 57 ⁇ , p.7209-7212
  • Non-Patent Document 2 "The Journal of Organic Chemistry” Organic Chemistry), 1968, 33 ⁇ , p.3201-3207
  • the problem to be solved by the present invention is that an amino protector of monohydroxy 2-adamantanamine, which is a raw material for monohydroxy-2-adamantanamine, which is useful as an intermediate for functional linseed drugs (for example, N — To provide a high-yield and stable production method using a microorganism of (monohydroxy-2-adamantyl) monophthalimide derivative).
  • the present inventors have intensively studied to achieve the above object.
  • the filamentous fungus isolated by the present inventors produces N- (monohydroxy-2-adamantyl) phthalimide derivative from N- (2-adamantyl) -phthalimide derivative. I found this for the first time.
  • N- (monohydroxy-2-adamantyl) phthalimide derivative was successfully produced in the medium, and the present invention was completed.
  • the present invention provides:
  • Filamentous fungi are genus Nakataea, Rhizoctonia, Caetumum (
  • the method according to (1) selected from the group of Chaetomium), The method according to (2) above, wherein the filamentous fungus is Nakataea sigmoidea Rhi zoctonia solani or 7 Chaotomium cochliodes.
  • N- (2-adamantyl) phthalimide derivative is a compound represented by the following formula:
  • N- (monohydroxy-2-adamantyl) phthalimide derivative is a compound represented by any one of the following formulae:
  • the method according to (1) comprising a step of culturing a filamentous fungus in a medium, and a step of separating the N- (monohydroxy-2-adamantyl) phthalimide derivative from the culture solution, (9)
  • A is a substituted or non-cyclic hydrocarbon group or a substituted or heterocyclic group
  • R 2 is a single bond or alkylene which may be substituted
  • X is a hydroxyl group, a halogen or a hydroxyl group derivative. is a leaving group wither
  • R 4 is is hydrogen or substituted, I also characterized by reacting a compound represented by alkyl as), formula ( ⁇ ):
  • the method for producing N- (monohydroxy-2-adamantyl) phthalimide derivatives of the present invention realizes stable production (supply) of N (monohydroxy-2-adamantyl) phthalimide derivatives. Hydroxy-2-adamantyl) It is possible to produce phthalimide derivatives efficiently and safely at low cost.
  • the microorganism of the present invention can be suitably used in the above-described method for producing N- (monohydroxy-2-adamantyl) -phthalimide derivatives.
  • the method for producing an N- (monohydroxy-2-adamantyl) -phthalimide derivative of the present invention comprises a yarn having the ability to produce N (monohydroxy-2-adamantyl) phthalimide derivative. Culturing the fungus in a medium, producing and accumulating N (monohydroxy-2-adamantyl) -phthalimide derivative in the medium, and collecting it.
  • the N- (2 adamantyl) phthalimide derivative is a compound that can be a starting material for the production method of the present invention.
  • other derivatives such as Partial force of benzene ring of phthaloyl group F, Cl, Br, I and other halogens, alkyls, hydroxys, alkoxys, nitros, aryls, arylalkyls, carboxys, esters, strong compounds such as rubermoyl
  • halogen such as F, Cl, Br, or I, halogen, alkyl, hydroxy, alkoxy, nitro, aryl, arylalkyl, carboxy, ester, rubamoyl, etc.
  • halogen such as F, Cl, Br, or I
  • halogen alkyl, hydroxy, alkoxy, nitro, aryl, arylalkyl, carboxy, ester, rubamoyl, etc.
  • the N- (monohydroxy-2-adamantyl) phthalimide derivative is a compound produced by the method of the present invention using an N- (2-adamantyl) phthalimide derivative as a starting material.
  • a particularly preferred embodiment is N— (5 hydroxy-12 adamantyl) monophthalimide or N— (6 hydroxy-12 adamantyl) monophthalimide.
  • Alkyl means a linear or branched alkyl group having 1 to 10 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl, isohexyl, n-heptyl, n-octyl, n-nonyl, n-decyl and the like.
  • alkyl having 1 to 6 or 1 to 4 carbon atoms, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl , Neopentyl, n-hexyl, isohexyl.
  • the alkyl part of alkoxy has the same meaning as the above alkyl.
  • Aryl means a monocyclic aromatic hydrocarbon group (eg phenyl) and a polycyclic aromatic hydrocarbon group. (Examples: 1-naphthyl, 2-naphthyl, 1-anthryl, 2-anthryl, 9-anthryl, 1-phenanthryl, 2-phenanthryl, 3-phenanthryl, 4-phenanthryl, 9-phenanthryl, etc.).
  • Arylalkyl means the above alkyl substituted with the above aryl. The alkoxy moiety of the alkoxy carb is similar to the above alkyl.
  • Cyclic hydrocarbon group includes “cycloalkyl”, “cycloalkenyl”, and “aryl”.
  • Cycloalkyl '' means a cyclic saturated hydrocarbon group having 3 to 15 carbon atoms, such as cyclopropenole, cyclobutinole, cyclopentinole, cyclohexinole, cycloheptinole, cyclooctyl, bridged cyclic carbonization. Examples thereof include a hydrogen group and a spiro hydrocarbon group.
  • “Bridged cyclic hydrocarbon group” includes a group formed by removing one hydrogen atom having 5 to 8 carbon atoms in which two or more rings share two or more atoms. To do. Specifically, bicyclo [2.1.0] pentyl, bicyclo [2.2.1] heptyl, bicyclo [2.2.2] octyl and bicyclo [3.2.1] octyl, tricyclo [2.2 .1.0] heptyl and the like.
  • the “spiro hydrocarbon group” includes a group formed by removing one hydrogen from a ring force in which two hydrocarbon rings are formed by sharing one carbon atom. Specific examples include spiro [3.4] octyl.
  • “Cycloalkenyl” means a cyclic unsaturated aliphatic hydrocarbon group having 3 to 7 carbon atoms, such as cyclopropyl, cyclobutene, cyclopentale, and cyclohexene.
  • Cycloalkenyl also includes bridging 4-nacyclic hydrocarbon groups and spiro hydrocarbon groups having unsaturated bonds in the ring.
  • Heterocyclic group includes “heteroaryl, heterocycle”.
  • Heteroaryl means a monocyclic aromatic heterocyclic group and a condensed aromatic heterocyclic group.
  • a monocyclic aromatic heterocyclic group may contain from 1 to 4 oxygen atoms, sulfur atoms, and Z or nitrogen atoms in the ring. Means a group which may have a bond at the position.
  • the fused aromatic heterocyclic group is oxygen 1 to 4 5- to 8-membered aromatic rings which may contain from 1 to 4 atoms, sulfur atoms, and / or nitrogen atoms in the ring, or other 5- to 8-membered aromatic carbocycles or other 5 It means a group which has a bond at any substitutable position when it is condensed with an ⁇ 8-membered aromatic heterocyclic ring.
  • furyl eg 2 furyl, 3 furyl
  • chael eg 2 chael, 3 chael
  • pyrrolyl eg 1 pyrrolyl, 2-pyrrolyl, 3-pyrrolyl
  • imidazolyl eg: 1 imidazolyl, 2 imidazolyl, 4 imidazolyl
  • pyrazolyl eg 1 pyrazolyl, 3-virazolyl, 4 pyrazolyl
  • triazolyl eg 1, 2, 4 triazole— 1-yl, 1, 2, 4-triazole
  • tetrazolyl eg 1-tetrazolyl, 2-tetrazolyl, 5-tetrazolyl
  • oxazolyl eg 2-oxazolyl, 4-oxazolyl, 5— Oxazolyl
  • isoxazolyl eg: 3-isoxazolyl, 4 isoxazolyl, 5 iso
  • pyridyl e.g. 2 pyridyl, 3 pyridyl, 4 pyridyl
  • pyridazil e.g. 3-pyridazil, 4-pyridazil
  • Pyrimidyl eg,
  • Heterocycle '' includes 1 to 4 oxygen atoms, sulfur atoms, and Z or nitrogen atoms in the ring! /, Or a bond at any substitutable position! / , Even! Means a non-aromatic bicyclic group.
  • such a non-aromatic heterocyclic group may be further bridged with an alkyl chain having 1 to 4 carbon atoms !, and may be a cycloalkane (preferably a 5-6 membered ring! /,) Or benzene.
  • the ring may be condensed. If it is non-aromatic, it may be saturated or unsaturated.
  • Alkylene includes a divalent group of 1 to 6 consecutive methylenes, and specific examples include methylene, ethylene, trimethylene, tetramethylene, pentamethylene and hexamethylene.
  • Examples of the “leaving group derived from a hydroxyl group” include one OMs, one OTs, one OTf, and one ONs.
  • Ms represents a methanesulfol group
  • Ts represents a para-toluenesulfol group
  • Tf represents a trifluoromethanesulfol group
  • Ns represents an ortho-trobenzenesulfol group.
  • N (monohydroxy-2-adamantyl) Any microorganism may be used as long as it is capable of producing a phthalimide derivative or a salt thereof.
  • Such microorganisms have, for example, the ability to produce N- (monohydroxy-2-adamantyl) -phthalimide derivatives and belong to the genus Nakataea, Rhizoctonia, and Chaetomium. The microorganism to which it belongs is listed.
  • Microorganisms having the ability to produce N (monohydroxy-2 adamantyl) phthalimide derivatives are obtained by culturing microorganisms in a suitable medium, preferably a liquid medium, and accumulating N- (monohydroxy-2 —Adamantyl) Searching can be done with or without phthalimide derivatives.
  • the detection of N— (monohydroxy-2-adamantyl) monophthalimide derivative in the medium is performed, for example, by HPLC using the N- (monohydroxy-2-adamantyl) monophthalimide derivative obtained by the present invention as a standard product. It can be carried out.
  • a specific example of the microorganism used in the present invention is the newly isolated RF-9402 strain as a microorganism having the ability to produce N- (monohydroxy-2-adamantyl) phthalimide derivatives.
  • This strain is a filamentous fungus belonging to the genus Rhizoctonia, and is an example of an N- (monohydroxy-2-adamantyl) monophthalimide derivative-producing bacterium that is most preferably used in the method of the present invention.
  • the strain is cultured under suitable conditions, it produces an N— (monohydroxy-2-adamantyl) phthalimide derivative outside the cell.
  • the present inventors have found that the RF-5733 strain belonging to the genus Chaetomium and the Na kataea RF-9475 strain have similar characteristics.
  • the RF-9402 strain grows vigorously on a potato dextrose agar medium, but does not form a clear colony and is partially felt or powdery.
  • the aerial mycelium is light brown to brown, with a width of 7-20 / ⁇ ⁇ , branched almost at right angles and constricted at the branch. It forms a brown sclerotia but no conidia or spores are seen.
  • the RF-5733 strain forms a subspherical to egg-shaped persevere that opens to the top on potato dextrose agar.
  • Persecia has two types of crests, one of which originates from the base and is thin and loosely wavy, while the other is straight at the bottom and spirals 3-5 times above.
  • the cyst is rod-shaped and contains 8 lemon-shaped ascospores. Ascospore size is 7.5-10. 0 X 6.5-5. O / zm.
  • the strain RF-9475 grows vigorously on potato dextrose agar and is accompanied by abundant aerial hyphae to form loose felt colonies.
  • the aerial mycelium is colorless and has a diameter of 1.0 to 2.
  • O ⁇ m and the vegetative mycelium in agar is brown and has a diameter of 2.0 to 5.
  • O / z m Formation of conidia nuclei and sexual reproductive organs is not observed on potato dextrose agar, corn meal agar, malt extract agar, etc.
  • Rhizoctonia sola-RF-9402 force Etomum 'cocliodes RF-5733, and Nakata Air Sigmoidea RF-9475, for example, preserved on a slant of potato dextrose agar, or supplemented with 10% glycerin It can be stably stored by freezing at -80 ° C or lower using potato dextrose broth as a protective agent.
  • RF-9402 strain, RF-5733 strain, and RF-9475 strain which are examples of N (monohydroxy-2 adamantyl) phthalimide derivative-producing bacteria
  • the bacteriological properties have changed significantly and are not immediately constant.
  • Fungi can be mutated by artificial or artificial means such as UV irradiation, X-ray irradiation, or mutagenic agents (eg, N-methinole N'-tro-N-trosoguanidine), which are commonly used. This is a well-known fact.
  • Such natural mutants and artificial mutants All strains belonging to filamentous fungi including different strains and capable of producing N- (monohydroxy-12-adamantyl) monophthalimide derivatives can be used in the present invention.
  • Filamentous fungi belonging to the genus Rhizoctonia include Rhizoctonia solani, Rhizoctonia aderholdii, Rhiz octonia aerea, Rhizoctonia alpina and the like.
  • the filamentous fungi belonging to the genus Etomyum are: Chetomium cochliodes, Chietomium funicola, Chaetomium inicum, Chaetomium olivac (Chaetomium olivac) ) And the like.
  • filamentous fungi belonging to the genus Nakataae include Nakataea curvularioides, Nakataea cylindrospora, Nak ataea fusispora, and the like.
  • an N- (monohydroxy-2 adamantyl) phthalimide derivative-producing bacterium belonging to a filamentous fungus is used in a medium suitable for the microorganism to be used, for example, a normal microorganism.
  • a nutrient source any medium containing a carbon source, a nitrogen source, and an inorganic salt that can be assimilated by the microorganisms used can be used even in a natural medium or a synthetic medium.
  • glucose, fructose, galactose, glycerol, soluble starch, glutamic acid, molasses, animal vegetable oil and the like can be used.
  • nitrogen source malt extract, corn steep liquor, meat extract, peptone, yeast extract, ammonium sulfate, sodium nitrate, urea and the like can be used.
  • inorganic salts capable of producing sodium, potassium, calcium, vitamins, magnesium, chlorine, sulfuric acid and other ions can be added to the medium.
  • inorganic substances and / or organic substances that help the growth of N- (monohydroxy-2-adamantyl) monophthalimide derivative-producing bacteria and promote the production of N- (monohydroxy-2-adamantyl) phthalimide derivatives.
  • the substance can be added appropriately.
  • inclusion agents such as hydroxypropyl mono- ⁇ -cyclodextrin, ⁇ -cyclodextrin, ⁇ -cyclodextrin, ⁇ -cyclodextrin, methyl-13-cyclodextrin and the like can be mentioned.
  • Rhizoctonia sola -RF— 9402 force Etomum 'cocliodes RF — 5733, Nakataae' sigmoidea RF — 9475
  • ⁇ (Monohydroxy-2-adamantyl) A method for culturing a phthalimide derivative-producing bacterium is most suitably a culture method under aerobic conditions, particularly a deep liquid culture method under aeration. The temperature suitable for cultivation is 10-30 ° C. In most cases, it is better to cultivate at 15-30 ° C. Production of N- (monohydroxy-2-adamantyl) phthalimide derivatives reaches the maximum in 3 to 10 days of culture for both shaking culture and tank culture, depending on the type of culture medium and culture conditions used. .
  • N- (monohydroxy-2-adamantyl) phthalimide derivatives should be separated according to standard methods. Specifically, for example, N- (monohydroxy-2-adamantyl) -phthalimide derivative can be isolated from the medium by solvent extraction, ion exchange chromatography, activated carbon treatment, crystallization, membrane separation, and the like. it can.
  • the culture conditions for efficiently producing N- (monohydroxy-2adamantyl) phthalimide derivatives are the composition of the medium components, the culture temperature, the stirring speed, the pH, the aeration rate, the culture time of the seed mother, The inoculation amount, etc. is adjusted or selected as appropriate according to the type of production strain used and external conditions. If there is foaming in liquid culture, add antifoaming agents such as silicone oil, vegetable oil, and surfactants alone or in a mixture and mix appropriately in the medium.
  • N- (2 adamantyl) phthalimide derivative lOgZL or more can be added in the dissolved state in the presence of an inclusion agent.
  • the method shown in the examples is improved to 2% at the start of culture and on the second day of culture. Conversion rate exceeding 80% can be obtained by adding 8% to it can.
  • the filamentous fungus can be used for biotransformation as a whole fungal mycelium or in the form of an extract containing hydroxylase.
  • the extract means a product obtained by crushing and treating fungal cells, and containing a soluble enzyme.
  • the enzymes of the extract, in particular the hydroxylase can be stabilized in some cases, for example by adding the natural cofactors, koffers, salts of the enzyme.
  • the hydroxylated enzyme of the extract can be used in a fixed form.
  • a method for producing a monosaccharide from an amino protector of 2 adamantanamin by using a bacterium belonging to the genus Nakataea, Rhizoctonia, or Chaetomium, or an extract thereof. Also included is a method for producing an amino-protected form of hydroxy 2-adamantanamine.
  • microorganisms described above can be used as microorganisms belonging to any one of the genus Nakataea, Rhizoctonia, or Chaeto mium.
  • any compound can be used as long as it is a compound in which the amino group of adamantanamin is protected.
  • the adamantane part other than the hydroxylated part is replaced with halogen such as F, Cl, Br, I, alkyl, hydroxy, alkoxy, nitro, aryl, aryl alkyl, carboxy, ester, force rumoyl, etc. It may be.
  • N— (2-adamantyl) monophthalimide derivatives N- (2-adamantyl) -phthalimide, N-benzoyl-2-adamantanamine derivatives, N-benzoyl-2-adamantanamines, N-acetyl-2-adamantanamine derivatives, N Acetyl 2-adadamantanamin.
  • the monoamino-2-adamantanamine amine protector means a compound in which the above-mentioned 2-adamantanamine amine protector is monohydroxylated.
  • the amino-protected form of monohydroxy-2-adadamantamine, N- (monohydroxy-2-adamantyl) phthalimide derivative, obtained by the present invention can be easily converted to monohydroxy-2-adamantanamine by removing the protecting group. Can do.
  • the fermented 24-well multiplate culture solution is stirred and extracted with 1 ml of acetone per well, then transferred to a 96-well deep plate, centrifuged at 2500 rpm for 15 minutes, and the supernatant is reversed. Subjected to phase HPLC analysis.
  • P5 and P6 were identified as peaks presumed to have been given one hydroxyl group by ESI-MS for the sample in which a new peak was detected.
  • the following three strains were selected as strains that efficiently convert the substrate to 80% or more of these compounds.
  • the spore-incomplete fungus RF-9475 produces approximately equal amounts of both P5 and P6 compounds, while Rhizoctonia 'sora-RF-9402 and Ketomyum cochliodes RF-5733 produce more than 80% of the substrate. Convert to P5 and P6 respectively.
  • [0028] [Seed culture] Glucose 2.0%, Soybean Minore 0.5%, East Etastrata KDifco) 0.5%, Sodium Chloride 0.5%, Potassium Phosphate 0.5% Tap water (adjusted to PH7, diluted hydrochloric acid) 100 ml of the medium was dispensed into a 500 ml wide-mouth flask and sterilized at 121 ° C for 20 minutes. Helminthosporium sigmoideum RF-9475 was scraped from the agar slant culture and cultured at 28 ° C for 2 days at an amplitude of 70 mm and 180 rpm. .
  • Tap water 100 ml of a medium having a composition was dispensed into 50 500 ml wide-neck flasks and sterilized at 121 ° C for 20 minutes.
  • 2-Adamantane phthalimide lOOmg per flask was made into a DMS02ml solution and added aseptically, then 4ml of seed culture was inoculated and cultured at 28 ° C for 4 days at an amplitude of 70mm and 180 rpm.
  • 57.2% of the substrate was converted to P5 and 43.7% of the substrate was converted to P6.
  • the fermentation finished solution for 50 flasks was extracted with 3 L of ethyl acetate and then re-extracted with 1 L of n-butanol. Both extracts were combined and concentrated to dryness under reduced pressure to obtain 11.39 g of a crude extract.
  • the obtained crude extract (11.39 g) was dissolved in ethyl acetate using a medium pressure ram (inner diameter: 3 cm, length: 50 cm) filled with 200 g of silica gel (MS gel D-150-60A, manufactured by Asahi Glass Co., Ltd.) The effective fraction was concentrated to dryness to obtain 5. Olg crude extract.
  • the effective fraction was concentrated under reduced pressure, and 1.36 g and 1.02 g were obtained as purified products of 2-adamantanephthalimide-P5 and P6 by lyophilization, respectively.
  • Tap water 100 ml of the medium having the composition shown below was dispensed into a 500 ml wide-mouth flask and sterilized at 121 ° C. for 20 minutes.
  • the medium was inoculated with Rhizoctonia solani RF-9402 strain from an agar slope culture, and cultured at 28 ° C for 3 days at an amplitude of 70 mm and 180 rpm for 3 days.
  • the fermentation finished liquid for 3 flasks was extracted with 150 ml of n-butanol.
  • the extract was concentrated to dryness under reduced pressure to obtain 0.253 g of a crude extract.
  • the effective fraction was concentrated under reduced pressure and freeze-dried to obtain 65.4 mg of 2-adamantanphthalimide-P5 purified product.
  • Tap Water (adjusted to PH7, diluted hydrochloric acid) 1 medium 500ml flask with glucose and glucose 1.0%, CS L 2.0 50 ml of medium with the composition of% tap water (adjusted to PH 7.0, dilute caustic soda) was dispensed into one 500 ml wide mouth flask, and sterilized at 121 ° C for 20 minutes.
  • 2-Adamantanephthalimide lOmg per flask was made into a DMSO 0.2ml solution and aseptically added, then 5ml of the seed culture was inoculated and cultured at 28 ° C for 3 days at an amplitude of 70mm and 180 rpm.
  • As a result of reverse phase HPLC analysis 23.6% of the substrate was converted to P5 and 1.1% of the substrate was converted to P6.
  • the fermentation finished liquid for two flasks was extracted with 100 ml of n-butanol.
  • the extract was concentrated to dryness under reduced pressure to obtain 0.097 g of a crude extract.
  • the resulting crude extract (0.097 g) was chromatographed on a Unison US—C 18 (inner diameter 2 cm, length 15 cm) column with a gradient of acetonitrile / water 20-95% (20 minutes) at a flow rate of 15 ml / min. .
  • the effective fraction was concentrated under reduced pressure, and lyophilized to obtain 2.4 mg and 0.1 mg as purified products of 2-adamantanephthalimide-P 5 and P6, respectively.
  • Methylhydrazine (776 mg) was added to an ethanol solution (20 ml) of compound l (2.0 g), and the mixture was heated to reflux for 24 hours. After completion of the reaction, the solvent was distilled off, and the residue was diluted with 2N aqueous hydrochloric acid (30 ml). The aqueous layer was washed with ethyl acetate (50 ml X 2) and then concentrated to about 1/3 under reduced pressure. The precipitated crystals were collected by filtration and washed with isopropyl alcohol. The target product 2 (890 mg) was obtained as colorless crystals.
  • N (monohydroxy-2-adamantyl) phthalimide derivatives which are useful as an intermediate for pharmaceuticals.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Indole Compounds (AREA)

Abstract

Disclosed is a process for production of an N-(monohydroxy-2-adamantyl)-phthalimide derivative, which is a compound useful as an intermediate for the production of a functional resin or pharmaceutical, in a high yield and at a low cost. A mold isolated from soil and belonging to the genus Nakataea, Rhizoctonia or Chaetomium can produce an N-(monohydroxy-2-adamantyl)-phthalimide derivative from an N-(2-adamantyl)-phthalimide derivative in a culture medium in a high yield.

Description

明 細 書  Specification
微生物によるァダマンタン水酸化体の製造方法  Method for producing adamantane hydroxide by microorganism
技術分野  Technical field
[0001] 本発明は、微生物を用いるモノヒドロキシ一 2—ァダマンタナミンのァミノ保護体 (た とえば、 N— (モノヒドロキシー 2—ァダマンチル) フタルイミド誘導体)の生産方法に 関する。モノヒドロキシ一 2—ァダマンタナミンのァミノ保護体は、モノヒドロキシ一 2— ァダマンタナミンの原料であり、モノヒドロキシー2—ァダマンタナミンは、医薬品の中 間体として有用である。  The present invention relates to a method for producing an amino protected form of monohydroxy-12-adamantanamine (eg, N- (monohydroxy-2-adamantyl) phthalimide derivative) using a microorganism. The monohydroxy-2-adamantanamine amine protector is a raw material of monohydroxy-2-adamantanamine, and monohydroxy-2-adamantanamine is useful as an intermediate for pharmaceuticals.
背景技術  Background art
[0002] フォトリソグラフィー分野における感光性榭脂などの機能性榭脂のモノマー (特許文 献 1)や、医薬品の分野における 11ベータ—ヒドロキシステロイド デヒドロゲナーゼ I 型酵素(11 β HSD1)の阻害剤(特許文献 2、 27ページ)として、ァダマンタンの水酸 化体は知られている。また、 DPPIV阻害剤としても、ァダマンチル基を有する化合物 が知られている。そしてこれらの化合物を合成する場合、ァダマンタンの水酸化体の 一部の置換基を保護したィ匕合物は、その反応性力も合成中間体として有用といえる  [0002] Monomers of functional resin such as photosensitive resin in the photolithography field (Patent Document 1) and inhibitors of 11 beta-hydroxysteroid dehydrogenase type I enzyme (11 β HSD1) in the pharmaceutical field (patent Hydroxide of adamantane is known as Reference 2, page 27). In addition, compounds having an adamantyl group are known as DPPIV inhibitors. When synthesizing these compounds, compounds that protect some of the substituents of adamantane hydroxides are useful as synthetic intermediates.
[0003] そして、微生物を用いたァダマンタン誘導体の水酸ィ匕体の生産方法は以前力 知ら れて 、る。例えば、ボーべリア'スルフレツセンス (Beauveria sulfurescens)の生体 内変換を用いて、ベンジルアミドで保護されたァダマンタミン誘導体の水酸ィ匕体を生 産できる(非特許文献 1)。また、フタルイミドで保護されたァダマンタン誘導体につい ても、スポロトリカム'スルフレツセンス(Sporotrichum sulfurescens)の生体内変 換により、ジヒドロキシ体を生産できることが報告されている (非特許文献 2)。 [0003] A method for producing an adamantane derivative hydroxide using a microorganism has been known for some time. For example, by using biotransformation of Beauveria sulfurescens, it is possible to produce adamantamine hydroxyammonium salt protected with benzylamide (Non-patent Document 1). In addition, it has been reported that an adamantane derivative protected with phthalimide can also produce a dihydroxy form by in vivo conversion of Sporotrichum sulfurescens (Non-patent Document 2).
特許文献 1:特開 2006 -63061  Patent Document 1: JP 2006-63061
特許文献 2:国際公開第 WO04Z056744号パンフレット  Patent Document 2: International Publication No. WO04Z056744 Pamphlet
非特許文献 1:「ジャーナルォブ オーガニックケミストリー(Journal of Organic Chemistry)」、 1992年、 57卷、 p.7209-7212  Non-Patent Document 1: “Journal of Organic Chemistry”, 1992, 57 卷, p.7209-7212
非特許文献 2 :「ザ ジャーナルォブ オーガニック ケミストリー (The Journal of Organic Chemistry)」、 1968年、 33卷、 p.3201— 3207 Non-Patent Document 2: "The Journal of Organic Chemistry" Organic Chemistry), 1968, 33 卷, p.3201-3207
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0004] 本発明の解決しょうとする課題は、機能性榭脂ゃ医薬品の中間体として有用である モノヒドロキシ - 2-ァダマンタナミンの原料となるモノヒドロキシ 2—ァダマンタナミ ンのァミノ保護体(たとえば、 N— (モノヒドロキシ一 2—ァダマンチル)一フタルイミド誘 導体)の微生物を用いた高収率かつ安定な製造方法を提供することにある。 [0004] The problem to be solved by the present invention is that an amino protector of monohydroxy 2-adamantanamine, which is a raw material for monohydroxy-2-adamantanamine, which is useful as an intermediate for functional linseed drugs (for example, N — To provide a high-yield and stable production method using a microorganism of (monohydroxy-2-adamantyl) monophthalimide derivative).
課題を解決するための手段  Means for solving the problem
[0005] 本発明者らは、上記の目的を達成すべく鋭意研究を行った。その結果、本発明者ら により土壌力 分離された糸状菌が以下に示すように、 N—(2—ァダマンチル)ーフ タルイミド誘導体から、 N- (モノヒドロキシー 2—ァダマンチル) フタルイミド誘導体 を生産することを初めて見出した。またこの糸状菌を用いて液体培養することにより、 N- (モノヒドロキシー 2—ァダマンチル) フタルイミド誘導体を培地中に高生産させ ることに成功し、本発明を完成した。 [0005] The present inventors have intensively studied to achieve the above object. As a result, as shown below, the filamentous fungus isolated by the present inventors produces N- (monohydroxy-2-adamantyl) phthalimide derivative from N- (2-adamantyl) -phthalimide derivative. I found this for the first time. Also, by liquid culture using this filamentous fungus, N- (monohydroxy-2-adamantyl) phthalimide derivative was successfully produced in the medium, and the present invention was completed.
[化 1]  [Chemical 1]
Figure imgf000003_0001
Figure imgf000003_0001
[0006] すなわち、本発明は、  That is, the present invention provides:
(1)糸状菌またはその抽出物を用いて、 N—(2—ァダマンチル) フタルイミド誘導 体を水酸化することを特徴とする、 N— (モノヒドロキシ一 2—ァダマンチル)一フタル イミド誘導体を生産する方法、  (1) Producing N- (monohydroxy-2-adamantyl) monophthalimide derivatives characterized by hydroxylating N- (2-adamantyl) phthalimide derivatives using filamentous fungi or extracts thereof Method,
(2)  (2)
糸状菌がナカタエァ属(Nakataea)、リゾクトニア属 (Rhizoctonia)、カェトミゥム属( Filamentous fungi are genus Nakataea, Rhizoctonia, Caetumum (
Chaetomium)の群から選択される、前記(1)記載の方法、 糸状菌がナカタエア ·シグモイデア(Nakataea sigmoidea)リゾクトニア ·ソラ- (Rhi zoctonia solani)ま 7こ ίま力エト ゥム ·コクリオテス (Chaetomium cochliodes)で ある、前記(2)記載の方法、 The method according to (1), selected from the group of Chaetomium), The method according to (2) above, wherein the filamentous fungus is Nakataea sigmoidea Rhi zoctonia solani or 7 Chaotomium cochliodes.
(4) (Four)
糸状菌により行われる、前記(1)〜(3)のいずれか 1項に記載の方法、 The method according to any one of (1) to (3), which is performed by a filamentous fungus,
(5) (Five)
糸状菌の抽出物により行われ、抽出物が水酸化酵素を含有する、前記(1)記載の方 法、 The method according to (1), wherein the method is performed with an extract of filamentous fungus, and the extract contains hydroxylase,
(6)  (6)
前記 N—(2—ァダマンチル) フタルイミド誘導体が以下の式で表わされる化合物で ある前記(1)記載の方法、 The method according to (1), wherein the N- (2-adamantyl) phthalimide derivative is a compound represented by the following formula:
[化 2] [Chemical 2]
Figure imgf000004_0001
Figure imgf000004_0001
(7)  (7)
前記 N— (モノヒドロキシー 2—ァダマンチル) フタルイミド誘導体が以下のいずれ かの式で表わされる化合物である前記(1)記載の方法、 The method according to (1), wherein the N- (monohydroxy-2-adamantyl) phthalimide derivative is a compound represented by any one of the following formulae:
[化 3] [Chemical 3]
Figure imgf000004_0002
Figure imgf000004_0002
(8)  (8)
糸状菌を培地中で培養する工程、及び培養液から前記 N— (モノヒドロキシ— 2—ァ ダマンチル) フタルイミド誘導体を分離する工程を含む、前記(1)記載の方法、 (9) The method according to (1), comprising a step of culturing a filamentous fungus in a medium, and a step of separating the N- (monohydroxy-2-adamantyl) phthalimide derivative from the culture solution, (9)
N- (モノヒドロキシー 2—ァダマンチル) フタルイミド誘導体を生産する能力を有す るナカタエァ属(Nakataea)、リゾクトニア属(Rhizoctonia)、カェトミゥム属(Chaet omium)の!、ずれかの属に属する微生物の菌体、  N- (monohydroxy-2-adamantyl) microorganisms belonging to the genus Nakakata, Rhizoctonia, Chaet omium, or any other genus that have the ability to produce phthalimide derivatives Body,
(10) (Ten)
ナカタエァ.シグモイデア RF— 9475株(FERM ABP— 10791)、リゾクトニア ·ソラ -RF— 9402株(FERM ABP— 10790)または力エトミゥム 'コクリオデス RF— 57 33株(FERM ABP— 10789)のいずれかの株、 Any of Nakata Sigmoidea RF— 9475 strain (FERM ABP—10791), Rhizoctonia Sora-RF— 9402 strain (FERM ABP— 10790), or Etomyum 'cocliodes RF— 57 33 strain (FERM ABP— 10789),
(11) (11)
以下の式で表される、いずれかの化合物、 Any compound represented by the following formula:
[化 4][Chemical 4]
Figure imgf000005_0001
Figure imgf000005_0001
(12)  (12)
ナカタエァ属(Nakataea)、リゾクトニア属(Rhizoctonia)、カェトミゥム属(Chaeto mium)の 、ずれかの属に属する微生物の菌またはその抽出物により、 2 ァダマン タナミンのアミノ保護体力 モノヒドロキシ一 2—ァダマンタナミンのァミノ保護体を生 産する方法、 According to the fungus of microorganisms belonging to any genus of Nakataea, Rhizoctonia, Chaeto mium, or an extract thereof, the amino-protective strength of 2 Adamantanamin monohydroxy 1-2-adamantananamin amino How to produce protective bodies,
(13) (13)
(1)〜(8)および(12)のいずれかに記載の方法により得られた、 N (モノヒドロキシ —2—ァダマンチル)—フタルイミド誘導体を脱保護することを特徴とする、化合物 (I)  Compound (I), characterized in that N (monohydroxy-2-adamantyl) -phthalimide derivative obtained by the method according to any one of (1) to (8) and (12) is deprotected
[化 5] [Chemical 5]
( I ) (I)
Figure imgf000005_0002
で示される化合物の製造方法。
Figure imgf000005_0002
The manufacturing method of the compound shown by these.
(14)  (14)
前記(13)記載の方法により得られた式 (I)で示される化合物を、  The compound represented by the formula (I) obtained by the method described in (13) above,
式(Π): A - R1 - R2 - R3 - X Formula (Π): A-R 1 -R 2 -R 3 -X
(式中、 Aは置換されて 、てもよ ヽ環式炭化水素基または置換されて 、てもよ 、複素 環式基であり、 R1は単結合、 C ( = 0)—、— O または— NR4—であり、 R2は単結 合または置換されていてもよいアルキレンであり、 R3は単結合または— C ( = 0)—で あり、 Xは水酸基、ハロゲンまたは水酸基力 導かれる脱離基であり、 R4は水素また は置換されて 、てもよ 、アルキルである)で示される化合物と反応させることを特徴と する、式 (ΠΙ) : (In the formula, A is a substituted or non-cyclic hydrocarbon group or a substituted or heterocyclic group, R 1 is a single bond, C (= 0) —, —O Or —NR 4 —, R 2 is a single bond or alkylene which may be substituted, R 3 is a single bond or —C (= 0) —, and X is a hydroxyl group, a halogen or a hydroxyl group derivative. is a leaving group wither, R 4 is is hydrogen or substituted, I also characterized by reacting a compound represented by alkyl as), formula (ΠΙ):
[化 6]  [Chemical 6]
Figure imgf000006_0001
Figure imgf000006_0001
で示される化合物の製造方法、  A method for producing a compound represented by:
に関する。  About.
発明の効果  The invention's effect
[0007] 本発明の N— (モノヒドロキシー 2 ァダマンチル) フタルイミド誘導体の製造法は 、安定した N (モノヒドロキシー 2—ァダマンチル) フタルイミド誘導体の生産'供 給を実現するものであり、 N (モノヒドロキシー 2—ァダマンチル) フタルイミド誘導 体を効率よぐ安全で安価に製造することが可能となる。また、本発明の微生物は、 上記 N— (モノヒドロキシ— 2—ァダマンチル)—フタルイミド誘導体の製造法に、好適 に使用することができる。  [0007] The method for producing N- (monohydroxy-2-adamantyl) phthalimide derivatives of the present invention realizes stable production (supply) of N (monohydroxy-2-adamantyl) phthalimide derivatives. Hydroxy-2-adamantyl) It is possible to produce phthalimide derivatives efficiently and safely at low cost. In addition, the microorganism of the present invention can be suitably used in the above-described method for producing N- (monohydroxy-2-adamantyl) -phthalimide derivatives.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0008] 次に、本発明を詳細に説明する。  Next, the present invention will be described in detail.
本発明の N— (モノヒドロキシ— 2—ァダマンチル)—フタルイミド誘導体の製造法は 、 N (モノヒドロキシー 2—ァダマンチル) フタルイミド誘導体の生産能を有する糸 状菌を培地で培養し、培地中に N (モノヒドロキシー 2—ァダマンチル)ーフタルイミ ド誘導体を生産'蓄積させ、これを採取することを含む。 The method for producing an N- (monohydroxy-2-adamantyl) -phthalimide derivative of the present invention comprises a yarn having the ability to produce N (monohydroxy-2-adamantyl) phthalimide derivative. Culturing the fungus in a medium, producing and accumulating N (monohydroxy-2-adamantyl) -phthalimide derivative in the medium, and collecting it.
[0009] N—(2 ァダマンチル) フタルイミド誘導体とは、本発明の生産方法の出発原料と なりうる化合物であり、実施例に示す N— (2—ァダマンチル)—フタルイミドの他、そ の誘導体、例えばフタロイル基のベンゼン環部分力 F、 Cl、 Br、 Iなどのハロゲン、ァ ルキル、ヒドロキシ、アルコキシ、ニトロ、ァリール、ァリールアルキル、カルボキシ、ェ ステル、力ルバモイルなどで置換されたィ匕合物や、ァダマンチル基の水酸ィ匕される以 外の部分が F、 Cl、 Br、 Iなどのハロゲン、アルキル、ヒドロキシ、アルコキシ、ニトロ、 ァリール、ァリールアルキル、カルボキシ、エステル、力ルバモイルなどで置換された 化合物、また、ベンゼン環部分及びァダマンタン部分が上記の置換基で置換された 化合物も含まれる。 [0009] The N- (2 adamantyl) phthalimide derivative is a compound that can be a starting material for the production method of the present invention. In addition to the N- (2-adamantyl) -phthalimide shown in the examples, other derivatives such as Partial force of benzene ring of phthaloyl group F, Cl, Br, I and other halogens, alkyls, hydroxys, alkoxys, nitros, aryls, arylalkyls, carboxys, esters, strong compounds such as rubermoyl Other than the hydroxyl group of the adamantyl group, it is substituted with halogen such as F, Cl, Br, or I, halogen, alkyl, hydroxy, alkoxy, nitro, aryl, arylalkyl, carboxy, ester, rubamoyl, etc. Also included are compounds in which the benzene ring moiety and the adamantane moiety are substituted with the above substituents.
[0010] N- (モノヒドロキシー 2—ァダマンチル) フタルイミド誘導体とは、 N— (2—ァダマ ンチル) フタルイミド誘導体を出発原料として本発明の方法によって生産される化 合物であり、実施例に示す N (モノヒドロキシー 2—ァダマンチル) フタルイミドの 他、その誘導体、例えばフタロイル基のベンゼン環力 F、 Cl、 Br、 Iなどのハロゲン、 アルキル、ヒドロキシ、アルコキシ、ニトロ、ァリール、ァリールアルキル、カルボキシ、 アルコキシカルボ-ル、力ルバモイルなどで置換される化合物も含まれる。特に、好 ましい態様としては、 N— (5 ヒドロキシ一 2 ァダマンチル)一フタルイミドもしくは、 N— (6 ヒドロキシ一 2 ァダマンチル)一フタルイミドである。  [0010] The N- (monohydroxy-2-adamantyl) phthalimide derivative is a compound produced by the method of the present invention using an N- (2-adamantyl) phthalimide derivative as a starting material. N (Monohydroxy-2-adamantyl) Phthalimide and other derivatives thereof, for example, benzene ring force of phthaloyl group F, Cl, Br, I and other halogens, alkyl, hydroxy, alkoxy, nitro, aryl, arylalkyl, carboxy, Also included are compounds that are substituted with alkoxy carbs, strong rubamoyl, and the like. A particularly preferred embodiment is N— (5 hydroxy-12 adamantyl) monophthalimide or N— (6 hydroxy-12 adamantyl) monophthalimide.
「アルキル」とは、炭素数 1〜10個の直鎖状又は分枝状のアルキル基を意味し、例え ば、メチル、ェチル、 n-プロピル、イソプロピル、 n-ブチル、イソブチル、 sec-ブチル、 t ert-ブチル、 n-ペンチル、イソペンチル、ネオペンチル、 n-へキシル、イソへキシル、 n -ヘプチル、 n-ォクチル、 n-ノニル、 n-デシル等が挙げられる。好ましくは、炭素数 1 〜6または 1〜4個のアルキルであり、例えば、メチル、ェチル、 n-プロピル、イソプロ ピル、 n-ブチル、イソブチル、 sec-ブチル、 tert-ブチル、 n-ペンチル、イソペンチル、 ネオペンチル、 n-へキシル、イソへキシルが挙げられる。アルコキシのアルキル部分 は、上記のアルキルと同意義である。  “Alkyl” means a linear or branched alkyl group having 1 to 10 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl, isohexyl, n-heptyl, n-octyl, n-nonyl, n-decyl and the like. Preferred is alkyl having 1 to 6 or 1 to 4 carbon atoms, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl , Neopentyl, n-hexyl, isohexyl. The alkyl part of alkoxy has the same meaning as the above alkyl.
「ァリール」とは、単環芳香族炭化水素基 (例:フエニル)及び多環芳香族炭化水素基 (例: 1—ナフチル、 2—ナフチル、 1—アントリル、 2—アントリル、 9—アントリル、 1— フエナントリル、 2—フエナントリル、 3—フエナントリル、 4—フエナントリル、 9—フエナ ントリル等)が挙げられる。ァリールアルキルは、上記のァリールで置換された上記ァ ルキルを意味する。アルコキシカルボ-ルのアルコキシ部分は、上記のアルキルと同 思 (¾る。 “Aryl” means a monocyclic aromatic hydrocarbon group (eg phenyl) and a polycyclic aromatic hydrocarbon group. (Examples: 1-naphthyl, 2-naphthyl, 1-anthryl, 2-anthryl, 9-anthryl, 1-phenanthryl, 2-phenanthryl, 3-phenanthryl, 4-phenanthryl, 9-phenanthryl, etc.). Arylalkyl means the above alkyl substituted with the above aryl. The alkoxy moiety of the alkoxy carb is similar to the above alkyl.
「環式炭化水素基」とは、「シクロアルキル」、「シクロアルケ-ル」、「ァリール」を包含 する。  “Cyclic hydrocarbon group” includes “cycloalkyl”, “cycloalkenyl”, and “aryl”.
「シクロアルキル」とは、炭素数 3〜15の環状飽和炭化水素基を意味し、例えば、シク 口プロピノレ、シクロブチノレ、シクロペンチノレ、シクロへキシノレ、シクロへプチノレ、シクロ ォクチル、橋かけ環式炭化水素基、スピロ炭化水素基などが挙げられる。  `` Cycloalkyl '' means a cyclic saturated hydrocarbon group having 3 to 15 carbon atoms, such as cyclopropenole, cyclobutinole, cyclopentinole, cyclohexinole, cycloheptinole, cyclooctyl, bridged cyclic carbonization. Examples thereof include a hydrogen group and a spiro hydrocarbon group.
「橋かけ環式炭化水素基」とは、 2つ以上の環が 2個またはそれ以上の原子を共有し ている炭素数 5〜8の脂肪族環力 水素を 1つ除いてできる基を包含する。具体的に はビシクロ [2. 1. 0]ペンチル、ビシクロ [2. 2. 1]ヘプチル、ビシクロ [2. 2. 2]オタ チルおよびビシクロ [3. 2. 1]ォクチル、トリシクロ [2. 2. 1. 0]ヘプチルなどが挙げら れる。 “Bridged cyclic hydrocarbon group” includes a group formed by removing one hydrogen atom having 5 to 8 carbon atoms in which two or more rings share two or more atoms. To do. Specifically, bicyclo [2.1.0] pentyl, bicyclo [2.2.1] heptyl, bicyclo [2.2.2] octyl and bicyclo [3.2.1] octyl, tricyclo [2.2 .1.0] heptyl and the like.
「スピロ炭化水素基」とは、 2つの炭化水素環が 1個の炭素原子を共有して構成され ている環力も水素を 1つ除いてできる基を包含する。具体的にはスピロ [3. 4]ォクチ ルなどが挙げられる。  The “spiro hydrocarbon group” includes a group formed by removing one hydrogen from a ring force in which two hydrocarbon rings are formed by sharing one carbon atom. Specific examples include spiro [3.4] octyl.
「シクロアルケニル」とは、炭素数 3〜7個の環状の不飽和脂肪族炭化水素基を意味 し、例えば、シクロプロべ-ル、シクロブテュル、シクロペンテ-ル、シクロへキセ-ル “Cycloalkenyl” means a cyclic unsaturated aliphatic hydrocarbon group having 3 to 7 carbon atoms, such as cyclopropyl, cyclobutene, cyclopentale, and cyclohexene.
、シクロヘプテュルが挙げられ、好ましくはシクロプロべ-ル、シクロブテュル、シクロ ペンテ-ル、シクロへキセ-ルである。シクロアルケ-ルには、環中に不飽和結合を 有する橋力 4ナ環式炭化水素基およびスピロ炭化水素基も含む。 And cycloheptyl, and cyclopropyl, cyclobutyl, cyclopentale, and cyclohexyl are preferred. Cycloalkenyl also includes bridging 4-nacyclic hydrocarbon groups and spiro hydrocarbon groups having unsaturated bonds in the ring.
「複素環式基」とは、 「ヘテロァリール、ヘテロサイクル」を包含する。  “Heterocyclic group” includes “heteroaryl, heterocycle”.
「ヘテロァリール」とは、単環芳香族複素環式基及び縮合芳香族複素環式基を意味 する。単環芳香族複素環式基は、酸素原子、硫黄原子、および Z又は窒素原子を 環内に 1〜4個含んでいてもよい 5〜8員の芳香環力 誘導される、置換可能な任意 の位置に結合手を有していてもよい基を意味する。縮合芳香族複素環式基は、酸素 原子、硫黄原子、および/又は窒素原子を環内に 1〜4個含んでいてもよい 5〜8員 の芳香環が、 1〜4個の 5〜8員の芳香族炭素環もしくは他の 5〜8員の芳香族へテロ 環と縮合して 、る、置換可能な任意の位置に結合手を有して 、てもよ 、基を意味す る。例えば、フリル(例: 2 フリル、 3 フリル)、チェ-ル(例: 2 チェ-ル、 3 チェ -ル)、ピロリル(例: 1 ピロリル、 2 -ピロリル、 3 -ピロリル)、イミダゾリル(例: 1 ィ ミダゾリル、 2 イミダゾリル、 4 イミダゾリル)、ピラゾリル(例: 1 ピラゾリル、 3—ビラ ゾリル、 4 ピラゾリル)、トリァゾリル(例: 1, 2, 4 トリァゾール— 1—ィル、 1, 2, 4- トリァゾール— 3—ィル、 1, 2, 4 トリァゾール— 4—ィル)、テトラゾリル(例: 1—テト ラゾリル、 2—テトラゾリル、 5—テトラゾリル)、ォキサゾリル(例: 2—ォキサゾリル、 4 ォキサゾリル、 5—ォキサゾリル)、イソキサゾリル(例: 3—イソキサゾリル、 4 イソキサ ゾリル、 5 イソキサゾリル)、チアゾリル(例: 2 チアゾリル、 4 チアゾリル、 5 チア ゾリル)、チアジアゾリル、イソチアゾリル(例: 3—イソチアゾリル、 4 イソチアゾリル、 5—イソチアゾリル)、ピリジル(例: 2 ピリジル、 3 ピリジル、 4 ピリジル)、ピリダジ -ル(例: 3 -ピリダジ -ル、 4 -ピリダジ -ル)、ピリミジ -ル(例: 2 -ピリミジ -ル、 4 - ピリミジ -ル、 5 -ピリミジ -ル)、フラザ-ル(例: 3 -フラザ-ル)、ピラジュル(例: 2 - ピラジュル)、ォキサジァゾリル(例:1, 3, 4 ォキサジァゾ一ルー 2 ィル)、ベンゾ フリル(例: 2 べンゾ [b]フリル、 3 べンゾ [b]フリル、 4一べンゾ [b]フリル、 5 ベン ゾ [b]フリル、 6 べンゾ [b]フリル、 7 べンゾ [b]フリル)、ベンゾチェ-ル(例: 2— ベンゾ [b]チェ-ル、 3—べンゾ [b]チェ-ル、 4一べンゾ [b]チェ-ル、 5—べンゾ [b ]チェ-ル、 6—べンゾ [b]チェ-ル、 7—べンゾ [b]チェ-ル)、ベンズイミダゾリル( 例: 1一べンゾイミダゾリル、 2 べンゾイミダゾリル、 4一べンゾイミダゾリル、 5 ベン ゾイミダゾリル)、ジベンゾフリル、ベンゾォキサゾリル、キノキサリル(例: 2—キノキサリ -ル、 5—キノキサリニル、 6—キノキサリニル)、シンノリ-ル(例: 3—シンノリ-ル、 4 —シンノリ-ル、 5—シンノリニル、 6—シンノリニル、 7—シンノリニル、 8—シンノリ-ル )、キナゾリル(例: 2 キナゾリ-ル、 4ーキナゾリ-ル、 5 キナゾリ-ル、 6 キナゾリ -ル、 7 キナゾリ-ル、 8 キナゾリ-ル)、キノリル(例: 2 キノリル、 3 キノリル、 4 —キノリル、 5—キノリル、 6—キノリル、 7—キノリル、 8—キノリル)、フタラジュル(例: 1—フタラジュル、 5 フタラジュル、 6 フタラジュル)、イソキノリル(例: 1—イソキノリ ル、 3—イソキノリル、 4 イソキノリル、 5—イソキノリル、 6—イソキノリル、 7—イソキノリ ル、 8 イソキノリル)、プリル、プテリジ-ル(例: 2 プテリジ-ル、 4ープテリジ-ル、 6—プテリジニル、 7—プテリジニル)、カルバゾリル、フエナントリジニル、アタリジニル (例: 1—アタリジ-ル、 2—アタリジ-ル、 3—アタリジ-ル、 4—アタリジ-ル、 9ーァク リジ -ル)、インドリル(例:1 インドリル、 2 インドリル、 3 インドリル、 4 インドリル 、 5 インドリル、 6 インドリル、 7 インドリル)、イソインドリル、ファナジ-ル(例: 1 フエナジ-ル、 2—フエナジ-ル)又はフエノチアジ-ル(例: 1 フエノチアジ-ル、 2 フエノチアジ-ル、 3—フエノチアジ-ル、 4 フエノチアジ-ル)等が挙げられる。 「ヘテロサイクル」とは、酸素原子、硫黄原子、及び Z又は窒素原子を環内に 1〜4個 含んで!/、てもよぐ置換可能な任意の位置に結合手を有して!/、てもよ!、非芳香族複 素環式基を意味する。また、そのような非芳香族複素環式基がさらに炭素数 1〜4の アルキル鎖で架橋されて!、てもよく、シクロアルカン(5〜6員環が好まし!/、)やべンゼ ン環が縮合していてもよい。非芳香族であれば、飽和でも不飽和でもよい。例えば、 1 ピロリニル、 2 ピロリニル、 3 ピロリニル、 1 ピロリジニル、 2 ピロリジニル、 3— ピロリジ -ル、 1 イミダゾリ-ル、 2 イミダゾリ-ル、 4 イミダゾリ-ル、 1 イミダゾリ ジ -ル、 2—イミダゾリジ -ル、 4—イミダゾリジ -ル、 1—ビラゾリ-ル、 3—ビラゾリ-ル 、 4ーピラゾリニル、 1ーピラゾリジニル、 3 ピラゾリジニル、 4ーピラゾリジニル、ピペリ ジ入 2 ピペリジニル、 3 ピペリジニル、 4ーピペリジニル、 1ーピペラジニル、 2— ピペラジニル、 2 モルホリニル、 3 モルホリニル、モルホリノ、テトラヒドロビラニル等 があげられる。 “Heteroaryl” means a monocyclic aromatic heterocyclic group and a condensed aromatic heterocyclic group. A monocyclic aromatic heterocyclic group may contain from 1 to 4 oxygen atoms, sulfur atoms, and Z or nitrogen atoms in the ring. Means a group which may have a bond at the position. The fused aromatic heterocyclic group is oxygen 1 to 4 5- to 8-membered aromatic rings which may contain from 1 to 4 atoms, sulfur atoms, and / or nitrogen atoms in the ring, or other 5- to 8-membered aromatic carbocycles or other 5 It means a group which has a bond at any substitutable position when it is condensed with an ˜8-membered aromatic heterocyclic ring. For example, furyl (eg 2 furyl, 3 furyl), chael (eg 2 chael, 3 chael), pyrrolyl (eg 1 pyrrolyl, 2-pyrrolyl, 3-pyrrolyl), imidazolyl (eg: 1 imidazolyl, 2 imidazolyl, 4 imidazolyl), pyrazolyl (eg 1 pyrazolyl, 3-virazolyl, 4 pyrazolyl), triazolyl (eg 1, 2, 4 triazole— 1-yl, 1, 2, 4-triazole) — 3-yl, 1, 2, 4 triazole— 4-yl), tetrazolyl (eg 1-tetrazolyl, 2-tetrazolyl, 5-tetrazolyl), oxazolyl (eg 2-oxazolyl, 4-oxazolyl, 5— Oxazolyl), isoxazolyl (eg: 3-isoxazolyl, 4 isoxazolyl, 5 isoxazolyl), thiazolyl (eg: 2 thiazolyl, 4 thiazolyl, 5 thiazolyl), thiadiazoly , Isothiazolyl (e.g. 3-isothiazolyl, 4 isothiazolyl, 5-isothiazolyl), pyridyl (e.g. 2 pyridyl, 3 pyridyl, 4 pyridyl), pyridazil (e.g. 3-pyridazil, 4-pyridazil) Pyrimidyl (eg, 2-pyrimidyl, 4-pyrimidyl, 5-pyrimidyl), Frazal (eg, 3-Furazal), Pyrazur (eg, 2-Pyrazur), Oxaziazolyl (Example) : 1, 3, 4 oxadiazol 2 yl), benzofuryl (ex. 2 benzo [b] furyl, 3 benzo [b] furyl, 4 benzo [b] furyl, 5 benzo [b] furyl, 6 benzo [b] furyl, 7 benzo [b] furyl), benzochel (e.g., 2-benzo [b] chael, 3-benzo [b] chael 4) Benzo [b] Chael, 5—Benzo [b] Chael, 6—Benzo [b] Chael, 7—Benzo [b] Chael) Benz imidazo (E.g. 1 benzoimidazolyl, 2 benzoimidazolyl, 4 benzoimidazolyl, 5 benzoimidazolyl), dibenzofuryl, benzoxazolyl, quinoxalyl (e.g. 2-quinoxalyl, 5 —Quinoxalinyl, 6-quinoxalinyl), cinnolyl (eg, 3-cinnolyl, 4-cinnonyl, 5-cinnolinyl, 6-cinnolinyl, 7-cinnolinyl, 8-cinnolinyl), quinazolyl (eg: 2 Quinazolyl, 4-quinazolyl, 5 quinazolyl, 6 quinazolyl, 7 quinazolyl, 8 quinazolyl), quinolyl (eg 2 quinolyl, 3 quinolyl, 4 —quinolyl, 5-quinolyl, 6— Quinolyl, 7-quinolyl, 8-quinolyl), phthaladur (eg 1-phthaladur, 5 phthaladur, 6 phthaladur), isoquinolyl (eg 1-isoquinolyl) , 3-isoquinolyl, 4 isoquinolyl, 5-isoquinolyl, 6-isoquinolyl, 7-isoquinolyl, 8 isoquinolyl), prill, pteridyl (eg, 2 pteridyl, 4-pteridyl, 6-pteridinyl, 7- Pteridinyl), carbazolyl, phenanthridinyl, atalidinyl (eg, 1-attaridyl, 2-ataridyl, 3--ataridyl, 4--ataridyl, 9-acrylidyl), indolyl (eg, 1) In-drill, 2-in-drill, 3-in-drill, 4-in-drill, 5-in-drill, 6-in-drill, 7-in-drill), iso-in-drill, fanadil (eg: 1 phenadyl, 2-phenadyl) or phenothiazine (eg: 1 phenothiazi-) , 2-phenothiazole, 3-phenothiazole, 4-phenothiazyl) and the like. `` Heterocycle '' includes 1 to 4 oxygen atoms, sulfur atoms, and Z or nitrogen atoms in the ring! /, Or a bond at any substitutable position! / , Even! Means a non-aromatic bicyclic group. In addition, such a non-aromatic heterocyclic group may be further bridged with an alkyl chain having 1 to 4 carbon atoms !, and may be a cycloalkane (preferably a 5-6 membered ring! /,) Or benzene. The ring may be condensed. If it is non-aromatic, it may be saturated or unsaturated. For example, 1 pyrrolinyl, 2 pyrrolinyl, 3 pyrrolinyl, 1 pyrrolidinyl, 2 pyrrolidinyl, 3-pyrrolidyl, 1 imidazolyl, 2 imidazolyl, 4 imidazolyl, 1 imidazolidyl, 2 imidazolidyl, 4-Imidazolidyl, 1-Virazolyl, 3-Virazolyl, 4-Pyrazolinyl, 1-Pyrazolidinyl, 3-Pyrazolidinyl, 4-Pyrazolidinyl, Piperidinylated 2 Piperidinyl, 3 Piperidinyl, 4-Piperidinyl, 1-Piperazinyl, 2-Piperazinyl, 2-Piperazinyl Examples thereof include morpholinyl, 3 morpholinyl, morpholino, tetrahydrobilanyl and the like.
「アルキレン」とは、メチレンが 1〜6個連続した 2価の基を包含し、具体的にはメチレ ン、エチレン、トリメチレン、テトラメチレン、ペンタメチレンおよびへキサメチレン等が 挙げられる。  “Alkylene” includes a divalent group of 1 to 6 consecutive methylenes, and specific examples include methylene, ethylene, trimethylene, tetramethylene, pentamethylene and hexamethylene.
「水酸基から導かれる脱離基」とは、一 OMs、 一 OTs、 一 OTf、 一 ONs等があげられ る。ここで、「Ms」はメタンスルホ-ル基、「Ts」はパラトルエンスルホ-ル基、「Tf」はト リフルォロメタンスルホ-ル基、「Ns」はオルト-トロベンゼンスルホ -ル基を表す。 本発明の方法で用いられる N— (モノヒドロキシ一 2—ァダマンチル)一フタルイミド 誘導体の生産能を有する糸状菌としては、 N (モノヒドロキシー 2—ァダマンチル) フタルイミド誘導体またはその塩を産生する能力を有する微生物であればいかな る微生物でもよい。このような微生物として、例えば、 N- (モノヒドロキシー 2—ァダマ ンチル)—フタルイミド誘導体の生産能を有し、かつ、ナカタエァ属(Nakataea)、リゾ クトニア属 (Rhizoctonia)、カェトミゥム属(Chaetomium)に属する微生物が挙げら れる。 Examples of the “leaving group derived from a hydroxyl group” include one OMs, one OTs, one OTf, and one ONs. Here, “Ms” represents a methanesulfol group, “Ts” represents a para-toluenesulfol group, “Tf” represents a trifluoromethanesulfol group, and “Ns” represents an ortho-trobenzenesulfol group. . As filamentous fungi having the ability to produce N- (monohydroxy-2-adamantyl) monophthalimide derivatives used in the method of the present invention, N (monohydroxy-2-adamantyl) Any microorganism may be used as long as it is capable of producing a phthalimide derivative or a salt thereof. Such microorganisms have, for example, the ability to produce N- (monohydroxy-2-adamantyl) -phthalimide derivatives and belong to the genus Nakataea, Rhizoctonia, and Chaetomium. The microorganism to which it belongs is listed.
[0012] N (モノヒドロキシー 2 ァダマンチル) フタルイミド誘導体の生産能を有する微 生物は、微生物を好適な培地、好ましくは液体培地で培養し、培養液中に蓄積され た N— (モノヒドロキシー 2—ァダマンチル) フタルイミド誘導体の有無によって、検 索することができる。培地中の N— (モノヒドロキシ一 2—ァダマンチル)一フタルイミド 誘導体の検出は、例えば、本発明により得られる N— (モノヒドロキシー 2—ァダマン チル)一フタルイミド誘導体を標準品として用いた HPLCにより、行うことができる。  [0012] Microorganisms having the ability to produce N (monohydroxy-2 adamantyl) phthalimide derivatives are obtained by culturing microorganisms in a suitable medium, preferably a liquid medium, and accumulating N- (monohydroxy-2 —Adamantyl) Searching can be done with or without phthalimide derivatives. The detection of N— (monohydroxy-2-adamantyl) monophthalimide derivative in the medium is performed, for example, by HPLC using the N- (monohydroxy-2-adamantyl) monophthalimide derivative obtained by the present invention as a standard product. It can be carried out.
[0013] 本発明に用いる微生物の具体的な例としては、 N— (モノヒドロキシー 2 ァダマン チル) フタルイミド誘導体生産能を有する微生物として、今回新たに分離した RF— 9402株がある。この菌株は、リゾクトニア属(Rhizoctonia)に属する糸状菌であり、 本発明の方法に最も好適に用いられる N— (モノヒドロキシ一 2—ァダマンチル)一フ タルイミド誘導体生産菌の一例である。同菌株は、好適な条件で培養すると、 N— ( モノヒドロキシ - 2-ァダマンチル) フタルイミド誘導体を菌体外に生産する。  [0013] A specific example of the microorganism used in the present invention is the newly isolated RF-9402 strain as a microorganism having the ability to produce N- (monohydroxy-2-adamantyl) phthalimide derivatives. This strain is a filamentous fungus belonging to the genus Rhizoctonia, and is an example of an N- (monohydroxy-2-adamantyl) monophthalimide derivative-producing bacterium that is most preferably used in the method of the present invention. When the strain is cultured under suitable conditions, it produces an N— (monohydroxy-2-adamantyl) phthalimide derivative outside the cell.
この他に、カェトミゥム属(Chaetomium)に属する RF— 5733株、ナカタエァ属(Na kataea) RF— 9475株についても同様の特徴を有することを見出した。  In addition, the present inventors have found that the RF-5733 strain belonging to the genus Chaetomium and the Na kataea RF-9475 strain have similar characteristics.
これらの菌学的性質を以下に記載する。  These mycological properties are described below.
[0014] RF— 9402株は、ポテトデキストロース寒天培地上での生育は旺盛だが、明瞭なコ ロニーを形成せず、部分的にフェルト状あるいは粉状を呈する。気中菌糸は淡褐色 〜褐色で、幅は 7— 20 /ζ πι、概ね直角に分枝し、分枝部でくびれる。茶褐色の菌核 を形成するが、分生子および胞子は見られない。  [0014] The RF-9402 strain grows vigorously on a potato dextrose agar medium, but does not form a clear colony and is partially felt or powdery. The aerial mycelium is light brown to brown, with a width of 7-20 / ζ πι, branched almost at right angles and constricted at the branch. It forms a brown sclerotia but no conidia or spores are seen.
RF— 5733株は、ポテトデキストロース寒天培地上で上部に開口した亜球形〜卵形 のペルセシァを形成する。ペルセシァは二種の頂毛を有し、一種は基部から生じ、 細く緩く波打ち、もう一方は下部がまっすぐで上は 3— 5回螺旋状に巻く。子嚢はこん 棒状で、 8個のレモン型の子嚢胞子を格納する。子嚢胞子のサイズは 7. 5 - 10. 0 X 6. 5-8. O /z mであった。 The RF-5733 strain forms a subspherical to egg-shaped persevere that opens to the top on potato dextrose agar. Persecia has two types of crests, one of which originates from the base and is thin and loosely wavy, while the other is straight at the bottom and spirals 3-5 times above. The cyst is rod-shaped and contains 8 lemon-shaped ascospores. Ascospore size is 7.5-10. 0 X 6.5-5. O / zm.
RF— 9475株は、ポテトデキストロース寒天培地上での生育は旺盛で、豊富な気中 菌糸を伴い、ルーズフェルト状のコロニーを形成する。気中菌糸は無色で直径 1. 0 〜2. O ^ m,寒天中の栄養菌糸は褐色で直径 2. 0〜5. O /z mである。ポテトデキス トロース寒天培地、コーンミール寒天培地、モルトエキス寒天培地などの上で、分生 子ゃ菌核、有性生殖器官の形成は認められない。  The strain RF-9475 grows vigorously on potato dextrose agar and is accompanied by abundant aerial hyphae to form loose felt colonies. The aerial mycelium is colorless and has a diameter of 1.0 to 2. O ^ m, and the vegetative mycelium in agar is brown and has a diameter of 2.0 to 5. O / z m. Formation of conidia nuclei and sexual reproductive organs is not observed on potato dextrose agar, corn meal agar, malt extract agar, etc.
これらの所見を基に、菌類図鑑 下(1977年 講談社)、 日本菌類誌 第三卷第三 号(1995年養賢堂)などで検索し、 RF— 9402株はリゾクトニア'ソラ- (Rhizoctoni a solani)ゝ RF— 5733株は力エトミゥム 'コクリオデス(Chaetomium cochlidodes )、RF— 9475株は ナカタエァ'シグモイデア(Nakataea sigmoidea)と同定し、リ ゾクトニア .ソラニ1¾^ 9402、力エトミゥム 'コクリオデス RF— 5733、ナカタエァ 'シグ モイデア RF— 9475とそれぞれ命名した。  Based on these findings, searches were made in the Fungal Encyclopedia (Kodansha, 1977) and the Japanese Fungal Journal No. 3-3 (Yokendo, 1995), and the RF-9402 strain was found to be Rhizoctoni a solani. ) ゝ RF— 5733 strain is identified as “Chaetomium cochlidodes”, RF— 9475 strain is identified as “Nakataea sigmoidea”, Rhizoctonia solani 1¾ ^ 9402, force Etomum ’s Sigmoidea RF—named 9475 respectively.
これらの糸状菌は、平成 19年 2月 26日に、独立行政法人産業技術総合研究所内 特許生物寄託センター (茨城県つくば巿東 1— 1— 1中央第 6)に、「Chaetomium cochlidodes RF— 5733」(受領番号 FERM ABP— 10789)、 「Rhizoctonia s olani RF— 9402」(受領番号 FERM ABP— 10790)および「Nakataea sigmoi dea RF— 9475」(受領番号 FERM ABP— 10791)なる表示で特許手続上の微 生物の寄託の国際的承認に関するブタペスト条約に基づいて国際寄託されている。  These filamentous fungi were released on February 26, 2007 at the Patent Organism Depositary Center (National Institute of Advanced Industrial Science and Technology, Ibaraki Prefecture 1-1-1 Central No. 6) “Chaetomium cochlidodes RF— 5733 (Reception number FERM ABP— 10789), “Rhizoctonia s olani RF— 9402” (reception number FERM ABP— 10790) and “Nakataea sigmoi dea RF— 9475” (reception number FERM ABP—10791). Deposited internationally under the Budapest Treaty on the International Approval of Deposits of Microorganisms.
[0015] リゾクトニア ·ソラ -RF— 9402、力エトミゥム 'コクリオデス RF— 5733、及びナカタ エア.シグモイデア RF— 9475は、例えば、ポテト'デキストロース寒天培地のスラント 上での保存、又は 10%グリセリンを添加したポテト'デキストロースブロスを保護剤とし て用いたマイナス 80°C以下での凍結保存により、安定に保存することができる。  [0015] Rhizoctonia sola-RF-9402, force Etomum 'cocliodes RF-5733, and Nakata Air Sigmoidea RF-9475, for example, preserved on a slant of potato dextrose agar, or supplemented with 10% glycerin It can be stably stored by freezing at -80 ° C or lower using potato dextrose broth as a protective agent.
[0016] 以上、 N (モノヒドロキシー 2 ァダマンチル) フタルイミド誘導体生産菌の一例 である、 RF— 9402株、 RF— 5733株、及び RF— 9475株について説明した力 一 般的には糸状菌類はその菌学的性状が極めて変化しやすぐ一定したものではない 。菌類は、自然的あるいは通常行われている紫外線照射、 X線照射、変異誘発剤( 例えば、 N メチノレ N' -トロー N -トロソグァ-ジンなど)を用 、た人為的変異 手段により変異することは周知の事実である。このような自然変異株ならびに人工変 異株も含め、糸状菌に属し、 N— (モノヒドロキシ一 2—ァダマンチル)一フタルイミド 誘導体を生産する能力を有する菌株はすべて本発明に使用することができる。 [0016] The power described above for the RF-9402 strain, RF-5733 strain, and RF-9475 strain, which are examples of N (monohydroxy-2 adamantyl) phthalimide derivative-producing bacteria, The bacteriological properties have changed significantly and are not immediately constant. Fungi can be mutated by artificial or artificial means such as UV irradiation, X-ray irradiation, or mutagenic agents (eg, N-methinole N'-tro-N-trosoguanidine), which are commonly used. This is a well-known fact. Such natural mutants and artificial mutants All strains belonging to filamentous fungi including different strains and capable of producing N- (monohydroxy-12-adamantyl) monophthalimide derivatives can be used in the present invention.
[0017] リゾクトニア属に属する糸状菌としては、リゾクトニア'ソラ- (Rhizoctonia solani)、 リゾクトニア ·アデロリデイイ (Rhizoctonia aderholdii)、リゾクトニア ·ァェレア(Rhiz octonia aerea)、リゾクトニア ·アルピナ(Rhizoctonia alpina)等が挙げられる。 力エトミゥム属に属する糸状菌としては、力エトミゥム 'コクリオデス(Chaetomium co chliodes)、力エトミゥム 'フニコラ (Chaetomium funicola)力エトミゥム 'インディ力 ム (Chaetomium indicum)、力エト ゥム ·オリノ セゥム (Chaetomium olivaceu m)等が挙げられる。 [0017] Filamentous fungi belonging to the genus Rhizoctonia include Rhizoctonia solani, Rhizoctonia aderholdii, Rhiz octonia aerea, Rhizoctonia alpina and the like. The filamentous fungi belonging to the genus Etomyum are: Chetomium cochliodes, Chietomium funicola, Chaetomium inicum, Chaetomium olivac (Chaetomium olivac) ) And the like.
ナカタエァ属に属する糸状菌としては、 Nakataea curvularioides (ナカタエア 力 一ブラリオイデス)、 Nakataea cylindrospora (ナカタエア シリンドロスポラ)、 Nak ataea fusispora (ナカタエア フシスボラ)等が挙げられる。  Examples of filamentous fungi belonging to the genus Nakataae include Nakataea curvularioides, Nakataea cylindrospora, Nak ataea fusispora, and the like.
[0018] 本発明の方法を実施するに当っては、糸状菌に属する N— (モノヒドロキシー 2 ァ ダマンチル) フタルイミド誘導体生産菌を、用いる微生物に好適な培地、例えば、 通常の微生物が利用しうる栄養物を含有する培地、好ましくは液体培地中にぉ 、て 培養する。本生産菌の培養には、微生物の培養に用いられる通常の培養方法が適 用される。栄養源としては、使用される微生物が資化しうる炭素源、窒素源および無 機塩などを程よく含有する培地であれば天然培地、合成培地の!/ヽずれでも利用でき る。 In carrying out the method of the present invention, an N- (monohydroxy-2 adamantyl) phthalimide derivative-producing bacterium belonging to a filamentous fungus is used in a medium suitable for the microorganism to be used, for example, a normal microorganism. Culturing in a medium containing a possible nutrient, preferably a liquid medium. For culturing the production bacteria, usual culture methods used for culturing microorganisms are applied. As a nutrient source, any medium containing a carbon source, a nitrogen source, and an inorganic salt that can be assimilated by the microorganisms used can be used even in a natural medium or a synthetic medium.
[0019] 用いる培地に含有される微生物が資化しうる炭素源としては、グルコース、フルクト ース、ガラクトース、グリセロール、可溶性デンプン、グルタミン酸、糖蜜、動'植物油 等を利用できる。また、窒素源としては、麦芽エキス、コーンスティープリカ一、肉ェキ ス、ペプトン、酵母エキス、硫酸アンモ-ゥム、硝酸ナトリウム、尿素などを使用できる 。そのほか必要に応じ、ナトリウム、カリウム、カルシウム、ビタミン類、マグネシウム、塩 素、硫酸およびその他のイオンを生成することができる無機塩類を培地中に添加す ることができる。また、使用する N— (モノヒドロキシ一 2—ァダマンチル)一フタルイミド 誘導体生産菌の発育を助け、 N- (モノヒドロキシー 2—ァダマンチル) フタルイミド 誘導体の生産を促進するような無機物質および (または)有機物質を適当に添加でき る。例えば、ヒドロキシプロピル一 β—シクロデキストリン、 α—シクロデキストリン、 β ーシクロデキストリン、 Ίーシクロデキストリン、メチルー 13ーシクロデキストリンなどの 包接剤が挙げられる。 [0019] As a carbon source that can be assimilated by the microorganisms contained in the medium to be used, glucose, fructose, galactose, glycerol, soluble starch, glutamic acid, molasses, animal vegetable oil and the like can be used. As the nitrogen source, malt extract, corn steep liquor, meat extract, peptone, yeast extract, ammonium sulfate, sodium nitrate, urea and the like can be used. In addition, if necessary, inorganic salts capable of producing sodium, potassium, calcium, vitamins, magnesium, chlorine, sulfuric acid and other ions can be added to the medium. In addition, inorganic substances and / or organic substances that help the growth of N- (monohydroxy-2-adamantyl) monophthalimide derivative-producing bacteria and promote the production of N- (monohydroxy-2-adamantyl) phthalimide derivatives. The substance can be added appropriately The For example, inclusion agents such as hydroxypropyl mono-β-cyclodextrin, α-cyclodextrin, β-cyclodextrin, Ί -cyclodextrin, methyl-13-cyclodextrin and the like can be mentioned.
[0020] リゾクトニア ·ソラ -RF— 9402、力エトミゥム 'コクリオデス RF— 5733、ナカタエァ 'シ グモイデア RF— 9475の生育に好適な培地としては、ポテト'デキストロース寒天培 地、麦芽エキス寒天培地、 V— 8ジュース寒天培地及びポテトキヤロット寒天培地が 挙げられる。  [0020] Rhizoctonia sola -RF— 9402, force Etomum 'cocliodes RF — 5733, Nakataae' sigmoidea RF — 9475 Suitable media for growing potato 'dextrose agar, malt extract agar, V-8 Examples include juice agar and potato carrot agar.
[0021] Ν (モノヒドロキシー 2—ァダマンチル) フタルイミド誘導体生産菌の培養方法に は、好気的条件下での培養法、特に通気下の深部液体培養法が最も適している。培 養に適当な温度は、 10〜30°Cである力 多くの場合 15〜30°Cで培養するのがよい 。 N— (モノヒドロキシー 2—ァダマンチル) フタルイミド誘導体の生産は、用いた培 地の種類や培養条件によって異なる力 振とう培養、タンク培養とも 3〜10日間の培 養でその蓄積量が最高に達する。  [0021] Ν (Monohydroxy-2-adamantyl) A method for culturing a phthalimide derivative-producing bacterium is most suitably a culture method under aerobic conditions, particularly a deep liquid culture method under aeration. The temperature suitable for cultivation is 10-30 ° C. In most cases, it is better to cultivate at 15-30 ° C. Production of N- (monohydroxy-2-adamantyl) phthalimide derivatives reaches the maximum in 3 to 10 days of culture for both shaking culture and tank culture, depending on the type of culture medium and culture conditions used. .
[0022] 培養物中に生産された N (モノヒドロキシー 2—ァダマンチル) フタルイミド誘導 体の蓄積量が最高に達した時点で培養を停止し、その培養物から、発酵生産物を採 取する一般的な方法に準じて N— (モノヒドロキシー 2—ァダマンチル) フタルイミド 誘導体の分離を行うのがよい。具体的には、例えば、溶媒抽出、イオン交換クロマト グラフィー、活性炭処理、結晶化、膜分離等により、 N- (モノヒドロキシー 2—ァダマ ンチル) -フタルイミド誘導体を培地力ゝら単離することができる。  [0022] When the accumulated amount of N (monohydroxy-2-adamantyl) phthalimide derivative produced in the culture reaches the maximum, the culture is stopped, and the fermentation product is collected from the culture. N- (monohydroxy-2-adamantyl) phthalimide derivatives should be separated according to standard methods. Specifically, for example, N- (monohydroxy-2-adamantyl) -phthalimide derivative can be isolated from the medium by solvent extraction, ion exchange chromatography, activated carbon treatment, crystallization, membrane separation, and the like. it can.
[0023] N- (モノヒドロキシー 2 ァダマンチル) フタルイミド誘導体を効率よく生産させる 培養条件は、前記培地成分の組成、培養温度、撹拌速度、 pH、通気量、種母の培 養時間、種母の接種量等を、使用する生産菌株の種類および外部条件等に応じて、 適宜に調節あるいは選択して設定する。液体培養において発泡がある場合は、シリ コーン油、植物油および界面活性剤等の消泡剤を単独または混合して適宜に培地 に配合する。  [0023] The culture conditions for efficiently producing N- (monohydroxy-2adamantyl) phthalimide derivatives are the composition of the medium components, the culture temperature, the stirring speed, the pH, the aeration rate, the culture time of the seed mother, The inoculation amount, etc. is adjusted or selected as appropriate according to the type of production strain used and external conditions. If there is foaming in liquid culture, add antifoaming agents such as silicone oil, vegetable oil, and surfactants alone or in a mixture and mix appropriately in the medium.
[0024] 包接剤存在下で N— (2 ァダマンチル) フタルイミド誘導体 lOgZL以上を溶解状 態で添加することも可能で、実施例に示した方法を改良し培養開始時に 2%、培養 2 日目に 8%を添加するなどの方法を取ることにより 80%を超える変換率を得ることが できる。 [0024] N- (2 adamantyl) phthalimide derivative lOgZL or more can be added in the dissolved state in the presence of an inclusion agent. The method shown in the examples is improved to 2% at the start of culture and on the second day of culture. Conversion rate exceeding 80% can be obtained by adding 8% to it can.
[0025] 糸状菌は、真菌菌糸全体としてまたは水酸化酵素を含有する抽出物の形で生体内 変換に使用することができる。抽出物とは、真菌の菌体を破砕して処理を施したもの であり、可溶性の酵素を含有するものを意味する。抽出物の酵素、特に水酸化酵素 は、場合によっては、例えば酵素の天然の補助因子、ノ ッファー、塩を加えることによ つて、安定ィ匕させることができる。抽出物の水酸ィ匕酵素は固定ィ匕型で使用することも できる。  [0025] The filamentous fungus can be used for biotransformation as a whole fungal mycelium or in the form of an extract containing hydroxylase. The extract means a product obtained by crushing and treating fungal cells, and containing a soluble enzyme. The enzymes of the extract, in particular the hydroxylase, can be stabilized in some cases, for example by adding the natural cofactors, koffers, salts of the enzyme. The hydroxylated enzyme of the extract can be used in a fixed form.
本発明には、ナカタエァ属(Nakataea)、リゾタト-ァ属(Rhizoctonia)、力エトミゥ ム属(Chaetomium)のいずれかの属に属する微生物の菌またはその抽出物により 、 2 ァダマンタナミンのァミノ保護体からモノヒドロキシ 2—ァダマンタナミンのアミ ノ保護体を生産する方法も包含される。  According to the present invention, there is provided a method for producing a monosaccharide from an amino protector of 2 adamantanamin by using a bacterium belonging to the genus Nakataea, Rhizoctonia, or Chaetomium, or an extract thereof. Also included is a method for producing an amino-protected form of hydroxy 2-adamantanamine.
ナカタエァ属(Nakataea)、リゾクトニア属(Rhizoctonia)、カェトミゥム属(Chaeto mium)のいずれかの属に属する微生物としては、上記に記載された微生物などを用 いることがでさる。  The microorganisms described above can be used as microorganisms belonging to any one of the genus Nakataea, Rhizoctonia, or Chaeto mium.
2—ァダマンタナミンのァミノ保護体としては、ァダマンタナミンのァミノ基が保護され た化合物であれば、いずれの化合物も包含される。なお、ァダマンタン部分の水酸 化される以外の部分が F、 Cl、 Br、 Iなどのハロゲン、アルキル、ヒドロキシ、アルコキ シ、ニトロ、ァリール、ァリールアルキル、カルボキシ、エステル、力ルバモイルなどで 置換されていてもよい。好ましくは、 N— (2—ァダマンチル)一フタルイミド誘導体、 N - (2—ァダマンチル)—フタルイミド、 N ベンゾィル—2—ァダマンタナミン誘導体、 N -ベンゾィル— 2—ァダマンタナミン、 N -ァセチル - 2-ァダマンタナミン誘導体 、 N ァセチル 2—ァダマンタナミンなどが挙げられる。  As the protected form of 2-adamantanamine, any compound can be used as long as it is a compound in which the amino group of adamantanamin is protected. In addition, the adamantane part other than the hydroxylated part is replaced with halogen such as F, Cl, Br, I, alkyl, hydroxy, alkoxy, nitro, aryl, aryl alkyl, carboxy, ester, force rumoyl, etc. It may be. Preferably, N— (2-adamantyl) monophthalimide derivatives, N- (2-adamantyl) -phthalimide, N-benzoyl-2-adamantanamine derivatives, N-benzoyl-2-adamantanamines, N-acetyl-2-adamantanamine derivatives, N Acetyl 2-adadamantanamin.
モノヒドロキシ - 2-ァダマンタナミンのァミノ保護体は、上記の 2—ァダマンタナミン のァミノ保護体がモノ水酸化された化合物を意味する。  The monoamino-2-adamantanamine amine protector means a compound in which the above-mentioned 2-adamantanamine amine protector is monohydroxylated.
本発明により得られた、モノヒドロキシ一 2—ァダマンタナミンのァミノ保護体、 N— (モ ノヒドロキシ 2—ァダマンチル) フタルイミド誘導体は、保護基をはずすことにより、 容易にモノヒドロキシ 2—ァダマンタナミンに変換することができる。  The amino-protected form of monohydroxy-2-adadamantamine, N- (monohydroxy-2-adamantyl) phthalimide derivative, obtained by the present invention can be easily converted to monohydroxy-2-adamantanamine by removing the protecting group. Can do.
[0026] 本発明を実施例により更に具体的に説明する。 実施例 1 [0026] The present invention will be described more specifically with reference to examples. Example 1
[0027] 以下に示す方法により社内の菌株ライブラリーをスクリーニングし、 2—ァダマンタン フタルイミド水酸ィ匕反応を行う株を見出した。  [0027] An in-house strain library was screened by the method shown below, and a strain that conducts 2-adamantane phthalimide hydroxide reaction was found.
[スクリーニング条件]  [Screening conditions]
グルコース 2. 0%、 ソィビーンミール 0. 5%、 イーストエタストラタ KDifco) 0. 5 %、塩化ナトリウム 0. 5%、 リン酸カリウム 0. 5%、 ヒドロキシプロピル- —シクロデ キストリン 1. 4%水道水(PH7に希塩酸で調整)の組成の培地 200mlを 121°C、 20 分間滅菌した。 2—ァダマンタンフタルイミド 40mgを DMSO溶液 (1. 0ml)として添 加した後、 1mlずつを無菌的に 24穴マルチプレート 8枚に分注し、変換用力ビライブ ラリーを胞子懸濁液として接種し、毎分 400回転 (丸菱バイオェンジ製 MBSS- 10 0)で、 28。C、 7曰間培養した。  Glucose 2.0%, Soybean Meal 0.5%, East Etastrata KDifco) 0.5%, Sodium Chloride 0.5%, Potassium Phosphate 0.5%, Hydroxypropyl--cyclodextrin 1.4% Tap Water ( 200 ml of medium with a composition of PH7 adjusted with dilute hydrochloric acid was sterilized at 121 ° C for 20 minutes. After adding 40 mg of 2-adamantanephthalimide as a DMSO solution (1.0 ml), each 1 ml is aseptically dispensed into 8 24-well multiplates, and the conversion force library is inoculated as a spore suspension. , 28 at 400 revolutions per minute (MBSS-10 0 manufactured by Maruhishi Bioengine). C, cultured for 7 hours.
[抽出'分析]  [Extract 'analysis]
発酵終了した 24穴マルチプレート培養液は、 1ゥエルあたり lmlのアセトンを力卩ぇ撹 拌抽出した後、 96穴ディーププレートに移し変え、毎分 2500回転で 15分間遠心分 離し、上澄み液を逆相 HPLC分析に供した。  The fermented 24-well multiplate culture solution is stirred and extracted with 1 ml of acetone per well, then transferred to a 96-well deep plate, centrifuged at 2500 rpm for 15 minutes, and the supernatant is reversed. Subjected to phase HPLC analysis.
[結果]  [Result]
変換反応の結果、新たなピークの検出されるサンプルについて ESI— MSにより水 酸基が 1つ付与したと推定されるピークとして P5、 P6を同定した。基質を 80%以上こ れらの化合物に効率的変換する株として以下の 3株を選択した。無胞子不完全菌 R F— 9475は P5、 P6に相当する化合物の両方をほぼ等量作るのに対し、リゾクトニア 'ソラ -RF— 9402株、及びケトミゥム 'コクリオデス RF— 5733は基質の 80%以上を それぞれ P5、 P6に変換する。  As a result of the conversion reaction, P5 and P6 were identified as peaks presumed to have been given one hydroxyl group by ESI-MS for the sample in which a new peak was detected. The following three strains were selected as strains that efficiently convert the substrate to 80% or more of these compounds. The spore-incomplete fungus RF-9475 produces approximately equal amounts of both P5 and P6 compounds, while Rhizoctonia 'sora-RF-9402 and Ketomyum cochliodes RF-5733 produce more than 80% of the substrate. Convert to P5 and P6 respectively.
なお、先行技術(ジャーナルォブ オーガニックケミストリー、 1992年、 57卷、 p.72 12-7216)に記載されるボーべリア'スルフレツセンス(またはボーべリア'バッシァー ナ) ATCC— 7159株についてもこの方法でスクリーニングを行った力 反応率は 20 %と顕著な水酸ィ匕体の生成は認められな力つた。  This method is also applied to Beauceria 'Sulfur Sense (or Beauveria' Bassiana) ATCC-7159 strain described in the prior art (Journal of Organic Chemistry, 1992, 57 卷, p.72 12-7216). The force response rate screened with the 20% response rate was 20%, indicating that no significant formation of hydroxide was observed.
実施例 2  Example 2
[0028] [種培養] グルコース 2. 0%、 ソィビーンミーノレ 0. 5%、 イーストエタストラタ KDifco)0. 5% 、 塩ィ匕ナトリウム 0. 5%、 リン酸カリウム 0. 5%水道水(PH7に調整、希塩酸)の組 成の培地 100mlを 500ml容広口フラスコに分注し、 121°C、 20分間滅菌した。この 培地に Helminthosporium sigmoideum (へノレミントスポリゥム シグモイデゥム) RF— 9475株を寒天斜面培養物よりかきとり接種し、振幅 70mm、毎分 180回転で、 28°C、 2日間培養し、種培養とした。 [0028] [Seed culture] Glucose 2.0%, Soybean Minore 0.5%, East Etastrata KDifco) 0.5%, Sodium Chloride 0.5%, Potassium Phosphate 0.5% Tap water (adjusted to PH7, diluted hydrochloric acid) 100 ml of the medium was dispensed into a 500 ml wide-mouth flask and sterilized at 121 ° C for 20 minutes. Helminthosporium sigmoideum RF-9475 was scraped from the agar slant culture and cultured at 28 ° C for 2 days at an amplitude of 70 mm and 180 rpm. .
[生体触媒反応] [Biocatalytic reaction]
グルコース 2. 0%、 ソィビーンミール 0. 5%、 イーストエタストラタ KDifco) 0. 5% 、 塩化ナトリウム 0. 5%、リン酸カリウム 0. 5%、ヒドロキシプロピル - j8—シクロデキス トリン 1. 4%水道水(PH7. 0に調整、希塩酸)の組成の培地 100mlを 500ml容広 口フラスコ 50本に分注し、 121°C、 20分間滅菌した。フラスコ当たり 2—ァダマンタン フタルイミド lOOmgを DMS02ml溶液とし、無菌的に添カ卩した後、種培養物 4mlず つ接種し、振幅 70mm、毎分 180回転で、 28°C、 4日間培養した。逆相 HPLC分析 の結果、 57. 2%の基質を P5に、 43. 7%の基質を P6に変換した。  Glucose 2.0%, Soybean meal 0.5%, East Etastrata KDifco) 0.5%, Sodium chloride 0.5%, Potassium phosphate 0.5%, Hydroxypropyl-j8-cyclodextrin 1.4% Tap water 100 ml of a medium having a composition (adjusted to PH 7.0, dilute hydrochloric acid) was dispensed into 50 500 ml wide-neck flasks and sterilized at 121 ° C for 20 minutes. 2-Adamantane phthalimide lOOmg per flask was made into a DMS02ml solution and added aseptically, then 4ml of seed culture was inoculated and cultured at 28 ° C for 4 days at an amplitude of 70mm and 180 rpm. As a result of reverse phase HPLC analysis, 57.2% of the substrate was converted to P5 and 43.7% of the substrate was converted to P6.
[抽出] [Extract]
フラスコ 50本分の発酵終了液は、酢酸ェチル 3Lで抽出した後、 n—ブタノール 1L で再抽出した。両抽出液を合わせ、減圧下、濃縮乾固し、 11. 39gの粗抽出物を得 た。  The fermentation finished solution for 50 flasks was extracted with 3 L of ethyl acetate and then re-extracted with 1 L of n-butanol. Both extracts were combined and concentrated to dryness under reduced pressure to obtain 11.39 g of a crude extract.
[単離,精製]  [Isolation and purification]
得られた粗抽出物 11. 39gはシリカゲル (MSゲル D— 150— 60A、旭硝子株式会 社製) 200gを充填した中圧力ラム (内径 3cm、 長さ 50cm)を用い、酢酸ェチルで溶 出し、有効画分を濃縮乾固し、 5. Olgの粗抽出物を得た。  The obtained crude extract (11.39 g) was dissolved in ethyl acetate using a medium pressure ram (inner diameter: 3 cm, length: 50 cm) filled with 200 g of silica gel (MS gel D-150-60A, manufactured by Asahi Glass Co., Ltd.) The effective fraction was concentrated to dryness to obtain 5. Olg crude extract.
得られた粗抽出物 5. Olgは、 Develosil UG— C18 15/30 (内径 5cm、長さ 50c m)カラムを用い、ァセトニトリル/水 0. 1%蟻酸酸性 30〜60%(40分)のダラディエ ント、流速 50ml/分でクロマトを行った。 The resulting crude extract 5. Olg was used in a Develosil UG—C18 15/30 (5 cm inner diameter, 50 cm long) column with acetonitrile / water 0.1% formic acid 30-60% (40 min) Chromatography was performed at a flow rate of 50 ml / min.
有効画分を減圧濃縮し、凍結乾燥により 2—ァダマンタンフタルイミド -P5、 P6 の 精製品として各々 1. 36g、 1. 02gを得た。 The effective fraction was concentrated under reduced pressure, and 1.36 g and 1.02 g were obtained as purified products of 2-adamantanephthalimide-P5 and P6 by lyophilization, respectively.
それぞれの物性値は以下の通りである。 2 -ァダマンタンフタルイミド- P5: Each physical property value is as follows. 2-Adamantanephthalimide-P5:
ESIMS mZz: 298 [M+H] +、 280[M+H— H20] +  ESIMS mZz: 298 [M + H] +, 280 [M + H— H20] +
'Η NMR(DMSO-d ) δ: 7.817(4H、 s)、 4.48(1H、 br. s)、 4.13(1H、 br. s) 'Η NMR (DMSO-d) δ: 7.817 (4H, s), 4.48 (1H, br. S), 4.13 (1H, br. S)
6  6
、 2.69(1H、 br. s)、 2.10(2H、 br. d、 J =〜13Hz)ゝ 2.05(1H、 m)、 1.78(2H 、 br. d、 J =〜12Hz)ゝ 1.70(2H、 br. d、 J =〜12Hz)ゝ 1.65(2H、 br. d、 J = 〜3Hz)、 1.44(2H、 br. d、 J =〜13Hz)  2.69 (1H, br.s), 2.10 (2H, br.d, J = ~ 13Hz) ゝ 2.05 (1H, m), 1.78 (2H, br.d, J = ~ 12Hz) ゝ 1.70 (2H, br d, J = ~ 12Hz) ゝ 1.65 (2H, br.d, J = ~ 3Hz), 1.44 (2H, br.d, J = ~ 13Hz)
13C NMR(DMSO-d ) δ : 168.96、 134.22、 131.43、 122.57、 65.48、 59. 13 C NMR (DMSO-d) δ: 168.96, 134.22, 131.43, 122.57, 65.48, 59.
6  6
50、 45.29、 45.15、 31.86、 31.20、 28.61  50, 45.29, 45.15, 31.86, 31.20, 28.61
2 -ァダマンタンフタルイミド- P6:  2-Adamantanephthalimide-P6:
ESIMS mZz: 298 [M+H] +、 280[M+H— H20] +  ESIMS mZz: 298 [M + H] +, 280 [M + H— H20] +
XH NMR(DMSO-d ) δ : 7.817(4H、 s)、 4.631(1H、 d、 J = 3.3Hz)、 4.17(1 XH NMR (DMSO-d) δ: 7.817 (4H, s), 4.631 (1H, d, J = 3.3Hz), 4.17 (1
6  6
H、 br. s)、 3.68(1H、 br. q、 J =〜3Hz)、 2.43(1H、 br. s)、 2.37(1H、 br. s) 、 2.305(1H、 dq、 J = 13.1、 3.1Hz)ゝ 2.224(1H、 dq、 J= 12.4、 3.0Hz)ゝ 1. 94(2H、 m)、 1.90(1H、 m)、 1.80(1H、 br. q、 J =〜3Hz)、 1.78(1H、 m)、 1. 72(1H、 br. q、 J =〜3Hz)、 1.54(2H、 br. d、 J =〜13Hz)  H, br.s), 3.68 (1H, br.q, J = ~ 3Hz), 2.43 (1H, br.s), 2.37 (1H, br.s), 2.305 (1H, dq, J = 13.1, 3.1 Hz) ゝ 2.224 (1H, dq, J = 12.4, 3.0Hz) ゝ 1.94 (2H, m), 1.90 (1H, m), 1.80 (1H, br.q, J = ~ 3Hz), 1.78 (1H M), 1.72 (1H, br.q, J = ~ 3Hz), 1.54 (2H, br.d, J = ~ 13Hz)
13C NMR(DMSO-d ) δ : 168.91、 134.19、 131.41、 122.54、 71.91、 60. 1 3 C NMR (DMSO-d) δ: 168.91, 134.19, 131.41, 122.54, 71.91, 60.
6  6
25、 36.42、 33.36、 32.79、 31.41、 31.34、 29.86、 29.11、 25.90 実施例 3  25, 36.42, 33.36, 32.79, 31.41, 31.34, 29.86, 29.11, 25.90 Example 3
[種培養]  [Seed culture]
グルコース 2. 0%、 ソィビーンミーノレ 0. 5%、 イーストエタストラタ KDifco)0. 5% 、 塩ィ匕ナトリウム 0. 5%、リン酸カリウム 0. 5%水道水(PH7に調整、希塩酸)の組成 の培地 100mlを 500ml容広口フラスコに分注し、 121°C、 20分間滅菌した。この培 地に Rhizoctonia solani (リゾクトニア ノラ-) RF— 9402株を寒天斜面培養物よ り接種し、振幅 70mm、毎分 180回転で、 28°C、 3日間培養し、種培養とした。  Glucose 2.0%, Soybean Minore 0.5%, East Etastrata KDifco) 0.5%, Sodium Chloride 0.5%, Potassium Phosphate 0.5% Tap water (adjusted to PH7, diluted hydrochloric acid) 100 ml of the medium having the composition shown below was dispensed into a 500 ml wide-mouth flask and sterilized at 121 ° C. for 20 minutes. The medium was inoculated with Rhizoctonia solani RF-9402 strain from an agar slope culture, and cultured at 28 ° C for 3 days at an amplitude of 70 mm and 180 rpm for 3 days.
[生体触媒反応] [Biocatalytic reaction]
グルコース 2.0%、 ソィビーンミール 0.5%、 イーストエタストラタ KDifco) 0.5%、 塩化ナトリウム 0.5%、 リン酸カリウム 0.5%、ヒドロキシプロピル - 一シクロデキスト リン 1.4%水道水(PH7に調整、希塩酸)の組成の培地 100mlを 500ml容広口フ ラスコ 3本に分注し、 121°C、 20分間滅菌した。フラスコ当たり 2—ァダマンタンフタ ルイミド 20mg、 40mg、 lOOmgを DMSO 0.4ml, 0.8ml, 2ml溶液とし、無菌的に 添カロした後、種培養物 4mlずつ接種し、振幅 70mm、毎分 180回転で、 28°C、 3 日間培養した。逆相 HPLC分析の結果、 88.2%の基質を P5に変換した。 100% medium with the composition of glucose 2.0%, soybean meal 0.5%, yeast ethastrata KDifco) 0.5%, sodium chloride 0.5%, potassium phosphate 0.5%, hydroxypropyl monocyclodextrin 1.4% tap water (adjusted to PH7, diluted hydrochloric acid) 500ml wide mouthpiece Dispersed into three Lasco and sterilized at 121 ° C for 20 minutes. 2-Adamantanephthalimide 20mg, 40mg, lOOmg per flask in DMSO 0.4ml, 0.8ml, 2ml solution, aseptically added and inoculated 4ml each of seed culture, amplitude 70mm, 180 rpm, 28 ° C, cultured for 3 days. As a result of reverse phase HPLC analysis, 88.2% of the substrate was converted to P5.
[抽出] [Extract]
フラスコ 3本分の発酵終了液は、 n—ブタノール 150mlで抽出した。抽出液は、減圧 下、濃縮乾固し、 0.253gの粗抽出物を得た。  The fermentation finished liquid for 3 flasks was extracted with 150 ml of n-butanol. The extract was concentrated to dryness under reduced pressure to obtain 0.253 g of a crude extract.
[単離,精製] [Isolation and purification]
得られた粗抽出物 0.253gは、 Unison US— C18 (内径 2cm、長さ 15cm)カラム を用い、ァセトニトリル/水 0.1%蟻酸酸性 30- 95%(20分)のグラディエント、流速 1 5ml/分でクロマトを行った。  0.253 g of the resulting crude extract was used with an Unison US—C18 (inner diameter 2 cm, length 15 cm) column, with a gradient of acetonitrile / water 0.1% formic acid 30-95% (20 min), flow rate 15 ml / min. Chromatography was performed.
有効画分を減圧濃縮し、凍結乾燥により 2—ァダマンタンフタルイミド -P5の精製品 65.4mgを得た。 The effective fraction was concentrated under reduced pressure and freeze-dried to obtain 65.4 mg of 2-adamantanphthalimide-P5 purified product.
実施例 4 Example 4
[種培養]  [Seed culture]
1) グルコース 2.0%、 ソィビーンミーノレ 0.5%、 イーストエタストラタ KDifco) 0.5 %、 塩化ナトリウム 0.5%、リン酸カリウム 0.5%水道水(PH7に調整、希塩酸)の組 成の培地 100mlを 500ml容広口フラスコに分注し、 121°C、 20分間滅菌した。この 培地にボーべリア ·バッシァーナ ATCC— 7159株を寒天斜面培養物より胞子懸濁 液とし接種し、振幅 70mm、毎分 180回転で、 28°C、 2日間培養し、種培養とした。 1) Glucose 2.0%, Soybean Minore 0.5%, Yeast Estrata KDifco) 0.5%, Sodium Chloride 0.5%, Potassium Phosphate 0.5% Medium of 100% tap water (adjusted to PH7, diluted hydrochloric acid) The flask was dispensed and sterilized at 121 ° C for 20 minutes. This medium was inoculated with Boberia vassiana ATCC-7159 strain as a spore suspension from an agar slant culture, cultured at 28 ° C for 2 days at an amplitude of 70 mm and 180 rpm, and used as a seed culture.
2) グルコース 10g、 C. S. L 20g水道水 1L (PH 7.0に調整、希苛性ソーダ)の 組成の培地 100mlを 500ml容広口フラスコに分注し、 121°C、 20分間滅菌した。こ の培地にボーべリア'バッシァーナ ATCC— 7159株を寒天斜面培養物より胞子懸 濁液とし接種し、振幅 70mm、毎分 180回転で、 28°C、 2日間培養し、種培養とした。 2) Glucose 10g, C. S. L 20g Tap water 1L (adjusted to PH 7.0, diluted caustic soda) 100ml medium was dispensed into a 500ml wide-necked flask and sterilized at 121 ° C for 20 minutes. This culture medium was inoculated with the Boberia 'Bassiana ATCC-7159 strain as a spore suspension from an agar slant culture, cultured at 28 ° C for 2 days at an amplitude of 70 mm and 180 rpm, and used as a seed culture.
[生体触媒反応] [Biocatalytic reaction]
グルコース 2.0%、 ソィビーンミール 0.5%、 イーストエタストラタ KDifco) 0.5%、 塩化ナトリウム 0.5%、リン酸カリウム 0.5%水道水(PH7に調整、希塩酸)の組成 の培地 50mlを含む 500ml容広口フラスコ 1本とグルコース 1.0%、 C. S. L 2.0 %水道水 (PH 7.0に調整、希苛性ソーダ)の組成の培地 50mlを 500ml容広口フ ラスコ 1本に分注し、 121°C、 20分間滅菌した。フラスコ当たり 2—ァダマンタンフタ ルイミド lOmgを DMSO 0.2ml溶液とし、無菌的に添カロした後、種培養物 5mlず つ接種し、振幅 70mm、毎分 180回転で、 28°C、 3日間培養した。逆相 HPLC分析 の結果、 23.6 %の基質を P5に、 1.1 %の基質を P6に変換した。 Glucose 2.0%, Soybean Meal 0.5%, Yeast Etastrata KDifco) 0.5%, Sodium Chloride 0.5%, Potassium Phosphate 0.5% Tap Water (adjusted to PH7, diluted hydrochloric acid) 1 medium 500ml flask with glucose and glucose 1.0%, CS L 2.0 50 ml of medium with the composition of% tap water (adjusted to PH 7.0, dilute caustic soda) was dispensed into one 500 ml wide mouth flask, and sterilized at 121 ° C for 20 minutes. 2-Adamantanephthalimide lOmg per flask was made into a DMSO 0.2ml solution and aseptically added, then 5ml of the seed culture was inoculated and cultured at 28 ° C for 3 days at an amplitude of 70mm and 180 rpm. As a result of reverse phase HPLC analysis, 23.6% of the substrate was converted to P5 and 1.1% of the substrate was converted to P6.
[抽出]  [Extract]
フラスコ 2本分の発酵終了液は、 n-ブタノール 100mlで抽出した。抽出液は、減圧 下、濃縮乾固し、 0. 097gの粗抽出物を得た。  The fermentation finished liquid for two flasks was extracted with 100 ml of n-butanol. The extract was concentrated to dryness under reduced pressure to obtain 0.097 g of a crude extract.
[単離,精製]  [Isolation and purification]
得られた粗抽出物 0. 097gは Unison US— C 18 (内径 2cm、長さ 15cm)カラムを 用い、ァセトニトリル/水 20— 95% (20分)のグラディエント、流速 15ml/分でクロマト を行った。有効画分を減圧濃縮し、凍結乾燥により 2—ァダマンタンフタルイミド -P 5、 P6 の精製品として各々 2. 4mg、 0. lmgを得た。  The resulting crude extract (0.097 g) was chromatographed on a Unison US—C 18 (inner diameter 2 cm, length 15 cm) column with a gradient of acetonitrile / water 20-95% (20 minutes) at a flow rate of 15 ml / min. . The effective fraction was concentrated under reduced pressure, and lyophilized to obtain 2.4 mg and 0.1 mg as purified products of 2-adamantanephthalimide-P 5 and P6, respectively.
実施例 5  Example 5
[0031] [ィ匕 7]  [0031] [7]
Figure imgf000020_0001
Figure imgf000020_0001
化合物 l(2.0g)のエタノール溶液 (20ml)にメチルヒドラジン (776mg)をカ卩え、 24時間加熱 還流を行った。反応終了後、溶媒を留去し、残渣を 2N塩酸水溶液 (30ml)で希釈した 。水層を酢酸ェチルで洗浄 (50ml X 2)した後に、減圧下、 1/3程度に濃縮した。析出し た結晶を濾取し、イソプロピルアルコールで洗浄した。 目的物 2(890mg)を無色結晶と して得た。  Methylhydrazine (776 mg) was added to an ethanol solution (20 ml) of compound l (2.0 g), and the mixture was heated to reflux for 24 hours. After completion of the reaction, the solvent was distilled off, and the residue was diluted with 2N aqueous hydrochloric acid (30 ml). The aqueous layer was washed with ethyl acetate (50 ml X 2) and then concentrated to about 1/3 under reduced pressure. The precipitated crystals were collected by filtration and washed with isopropyl alcohol. The target product 2 (890 mg) was obtained as colorless crystals.
NMR(d6-DMSO); 1.33— 1.42(m,2H), 1.58-1.72(m,6H), 1.85— 1.95(m,2H), 1.98— 2.05( m,lH), 2.06-2.14(m,2H), 3.18— 3.28(m,lH), 8.10— 8.20(br, 3H).  NMR (d6-DMSO); 1.33-1.42 (m, 2H), 1.58-1.72 (m, 6H), 1.85-1.95 (m, 2H), 1.98-2.05 (m, lH), 2.06-2.14 (m, 2H ), 3.18- 3.28 (m, lH), 8.10-8.20 (br, 3H).
実施例 6  Example 6
[0032] [化 8]
Figure imgf000021_0001
[0032] [Chemical 8]
Figure imgf000021_0001
化合物 3(150mg)のジメチルホルムアミド溶液(DMF) (5ml)に、窒素雰囲気下、モノヒ ドロキシ一 2 ァダマンタナミン (140mg)、 1-ヒドロキシベンゾトリアゾール(HOBT) (31 mg)、 1- (3-ジメチルァミノプロピル)- 3-ェチルカルボジイミド塩酸塩 (WSC) (174mg)、 トリェチルァミン (TEA) (180 1)を加え、室温で 14時間攪拌した。反応終了後、 2N塩 酸水溶液 (30ml)を加え、酢酸ェチルで抽出した。有機層を飽和炭酸水素ナトリウム水 溶液、飽和食塩水の順に洗浄し、硫酸マグネシウムで乾燥した。溶媒を留去し、残渣 をシリカゲルクロマトグラフィーで精製し、化合物 4(226mg)を得た。 To a dimethylformamide solution (DMF) (5 ml) of compound 3 (150 mg) in a nitrogen atmosphere, monohydroxy-2-adamantanamine (140 mg), 1-hydroxybenzotriazole (HOBT) (31 mg), 1- (3-dimethyla Minopropyl) -3-ethylcarbodiimide hydrochloride (WSC) (174 mg) and triethylamine (TEA) (1801) were added, and the mixture was stirred at room temperature for 14 hours. After completion of the reaction, 2N aqueous hydrochloric acid solution (30 ml) was added and extracted with ethyl acetate. The organic layer was washed with a saturated aqueous sodium hydrogen carbonate solution and saturated brine in that order, and dried over magnesium sulfate. The solvent was distilled off, and the residue was purified by silica gel chromatography to obtain compound 4 (226 mg).
NMR:(CDC13);1.06(d,J=6.6Hz,6H),1.53-2.20(m,14H),3.72(s,3H),3.98(d,J=6.6Hz,2H ),6.25-6.30(m,lH),7.71(s,lH) NMR: (CDC13); 1.06 (d, J = 6.6Hz, 6H), 1.53-2.20 (m, 14H), 3.72 (s, 3H), 3.98 (d, J = 6.6Hz, 2H), 6.25-6.30 ( m, lH), 7.71 (s, lH)
産業上の利用可能性 Industrial applicability
機能性榭脂ゃ医薬品の中間体として有用である N (モノヒドロキシー 2 ァダマン チル) フタルイミド誘導体の安価で高収率の製造方法として利用することができる。  It can be used as a low-cost and high-yield production method for N (monohydroxy-2-adamantyl) phthalimide derivatives, which are useful as an intermediate for pharmaceuticals.

Claims

請求の範囲 The scope of the claims
[1] 糸状菌またはその抽出物を用いて、 N—(2—ァダマンチル) フタルイミド誘導体を 水酸化することを特徴とする、 N— (モノヒドロキシ一 2—ァダマンチル)一フタルイミド 誘導体を生産する方法。  [1] A method for producing an N- (monohydroxy-2-adamantyl) monophthalimide derivative, characterized by hydroxylating an N- (2-adamantyl) phthalimide derivative using a filamentous fungus or an extract thereof.
[2] 糸状菌がナカタエァ属(Nakataea)、リゾクトニア属 (Rhizoctonia)、カェトミゥム属([2] Fungi are genus Nakataea, Rhizoctonia, Caetumum (
Chaetomium)の群から選択される、請求項 1記載の方法。 2. The method of claim 1, wherein the method is selected from the group of Chaetomium.
[3] 糸状菌がナカタエア'シグモイデア(Nakataea sigmoidea)リゾクトニア'ソラ - (Rhi zoctonia solani) *7こ ίま力エト ゥム ·コクリオテス (Chaetomium cochliodes)で ある、請求項 2記載の方法。 [3] The method according to claim 2, wherein the filamentous fungus is Nakataea sigmoidea Rhizoctonia solani * 7 Chaotomium cochliodes.
[4] 糸状菌により行われる、請求項 1〜3のいずれか 1項に記載の方法。 [4] The method according to any one of claims 1 to 3, which is performed by a filamentous fungus.
[5] 糸状菌の抽出物により行われ、抽出物が水酸化酵素を含有する、請求項 1記載の方 法。 [5] The method according to claim 1, wherein the method is performed with an extract of filamentous fungi, and the extract contains hydroxylase.
[6] 前記 N—(2 ァダマンチル) フタルイミド誘導体が以下の式で表わされる化合物で ある請求項 1記載の方法。  6. The method according to claim 1, wherein the N- (2 adamantyl) phthalimide derivative is a compound represented by the following formula:
[化 1]  [Chemical 1]
Figure imgf000022_0001
Figure imgf000022_0001
前記 N— (モノヒドロキシー 2—ァダマンチル) フタルイミド誘導体が以下のいずれ かの式で表わされる化合物である請求項 1記載の方法。  2. The method according to claim 1, wherein the N- (monohydroxy-2-adamantyl) phthalimide derivative is a compound represented by any one of the following formulae.
[化 2]  [Chemical 2]
Figure imgf000022_0002
Figure imgf000022_0002
糸状菌を培地中で培養する工程、及び培養液から前記 N (モノヒドロキシ ダマンチル) フタルイミド誘導体を分離する工程を含む、請求項 1記載の方法。 A step of culturing the filamentous fungus in the medium, and said N (monohydroxy) from the culture solution 2. The method of claim 1, comprising the step of separating the damantyl) phthalimide derivative.
[9] N- (モノヒドロキシー 2 ァダマンチル) フタルイミド誘導体を生産する能力を有す るナカタエァ属(Nakataea)、リゾクトニア属(Rhizoctonia)、カェトミゥム属(Chaet omium)の!、ずれかの属に属する微生物の菌体。 [9] N- (monohydroxy-2 adamantyl) microorganisms belonging to the genus Nakakata, Rhizoctonia, Chaet omium, or any genus that have the ability to produce phthalimide derivatives Cells.
[10] ナカタエァ'シグモイデア RF— 9475株(FERM ABP— 10791)、リゾクトニア ·ソラ[10] Nakata's Sigmoidea RF— 9475 (FERM ABP— 10791), Rhizoctonia Sola
-RF 9402株(FERM ABP— 10790)または力エトミゥム 'コクリオデス RF— 57-RF 9402 strain (FERM ABP— 10790) or force Etomum 'cocliodes RF— 57
33株(FERM ABP— 10789)のいずれかの株。 Any of 33 strains (FERM ABP-10789).
[11] 以下の式で表される、いずれかの化合物。 [11] Any compound represented by the following formula:
[化 3]  [Chemical 3]
Figure imgf000023_0001
Figure imgf000023_0001
[12] ナカタエァ属(Nakataea)、リゾクトニア属(Rhizoctonia)、カェトミゥム属(Chaeto mium)の 、ずれかの属に属する微生物の菌またはその抽出物により、 2 ァダマン タナミンのアミノ保護体力 モノヒドロキシ一 2—ァダマンタナミンのァミノ保護体を生 産する方法。  [12] Nadamantanamamine's amino-protective capacity by using microorganisms belonging to any genus of Nakataea, Rhizoctonia, or Chaeto mium, or its extract. How to produce an amino protector of adamantanamin.
[13] 請求項 1〜8および 12のいずれかに記載の方法により得られた、 N— (モノヒドロキシ —2—ァダマンチル)—フタルイミド誘導体を脱保護することを特徴とする、化合物 (I)  [13] Compound (I) characterized by deprotecting an N- (monohydroxy-2-adamantyl) -phthalimide derivative obtained by the method according to any one of claims 1 to 8 and 12.
[化 4][Chemical 4]
Figure imgf000023_0002
Figure imgf000023_0002
で示される化合物の製造方法。  The manufacturing method of the compound shown by these.
請求項 13記載の方法により得られた式 (I)で示される化合物を、  A compound represented by the formula (I) obtained by the method according to claim 13,
式(Π): A— R1— R2— R3— X (式中、 Aは置換されて 、てもよ ヽ環式炭化水素基または置換されて 、てもよ 、複素 環式基であり、 R1は単結合、— C ( = 0)—、— O—または— NR4—であり、 R2は単結 合または置換されていてもよいアルキレンであり、 R3は単結合または— C ( = 0)—で あり、 Xは水酸基、ハロゲンまたは水酸基力 導かれる脱離基であり、 R4は水素また は置換されて 、てもよ 、アルキルである)で示される化合物と反応させることを特徴と する、式 (ΠΙ) : Formula (Π): A— R 1 — R 2 — R 3 — X (In the formula, A is a substituted or non-cyclic hydrocarbon group or a substituted or heterocyclic group, R 1 is a single bond, —C (= 0) —, — O—or—NR 4 —, R 2 is a single bond or optionally substituted alkylene, R 3 is a single bond or —C (= 0) —, X is a hydroxyl group, a halogen or a hydroxyl group A force-guided leaving group, wherein R 4 is hydrogen or substituted, but may be alkyl)).
[化 5][Chemical 5]
Figure imgf000024_0001
Figure imgf000024_0001
で示される化合物の製造方法。 The manufacturing method of the compound shown by these.
PCT/JP2007/056542 2006-03-31 2007-03-28 Process for production of hydroxylated adamantane using microorganism WO2007114125A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008508544A JPWO2007114125A1 (en) 2006-03-31 2007-03-28 Method for producing adamantane hydroxide by microorganism

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006096279 2006-03-31
JP2006-096279 2006-03-31

Publications (1)

Publication Number Publication Date
WO2007114125A1 true WO2007114125A1 (en) 2007-10-11

Family

ID=38563394

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/056542 WO2007114125A1 (en) 2006-03-31 2007-03-28 Process for production of hydroxylated adamantane using microorganism

Country Status (3)

Country Link
JP (1) JPWO2007114125A1 (en)
TW (1) TW200808970A (en)
WO (1) WO2007114125A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008142986A1 (en) * 2007-05-18 2008-11-27 Shionogi & Co., Ltd. NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE HAVING 11 β-HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORY ACTIVITY
WO2009041470A1 (en) * 2007-09-27 2009-04-02 Shionogi & Co., Ltd. Method for producing hydroxylated adamantane using cytochrome p450
EP2243479A2 (en) 2009-04-20 2010-10-27 Abbott Laboratories Novel amide and amidine derivates and uses thereof
WO2011078101A1 (en) 2009-12-22 2011-06-30 塩野義製薬株式会社 Adamantanamine derivative
WO2012124781A1 (en) 2011-03-17 2012-09-20 塩野義製薬株式会社 Method for producing pyrazolecarboxylic acid derivative
US8324265B2 (en) 2005-11-21 2012-12-04 Shionogi & Co., Ltd. Heterocyclic compounds having type I 11β hydroxysteroid dehydrogenase inhibitory activity
US8901316B2 (en) 2010-08-09 2014-12-02 Shionogi & Co., Ltd. Process for preparing aminoadamantyl carbamate derivatives

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056744A1 (en) * 2002-12-23 2004-07-08 Janssen Pharmaceutica N.V. Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001017193A (en) * 1999-07-08 2001-01-23 Sumitomo Chem Co Ltd Production of monohydroxyadamantane esters
JP2001017194A (en) * 1999-07-08 2001-01-23 Sumitomo Chem Co Ltd Production of monohydroxyadamantane derivative
JP4371414B2 (en) * 2004-02-18 2009-11-25 ダイセル化学工業株式会社 Method for producing adamantanol

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056744A1 (en) * 2002-12-23 2004-07-08 Janssen Pharmaceutica N.V. Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HERR M.E. ET AL.: "The Microbiological Oxygenation of Acylated 1-Adamantanamines. Stereochemistry and Structural Determinations", J. ORG. CHEM., vol. 33, no. 8, 1968, pages 3201 - 3207, XP003018058 *
JOHNSON R.A. ET AL.: "Selective Oxygenation of Adamantanes and Other Substrates by Beauveria sulfurescens", J. ORG. CHEM., vol. 57, no. 26, 1992, pages 7209 - 7212, XP003018057 *
LIU Z.L. ET AL.: "Polymorphism of Genes Coding for Nuclear 18S rRNA Indicates Genetic Distinctiveness of Anastomosis Group 10 from Other Groups in the Rhizoctonia solani Species Complex", APPL. ENVIRON. MICROBIOL., vol. 61, no. 7, 1995, pages 2659 - 2664, XP002124048 *
NYVALL R.F. ET AL.: "Development of Fungal Brown Spot and Spot Blotch on Cultivated Wild Rice in Minnesota", PLANT DISEASE, vol. 83, no. 10, 1999, pages 936 - 938, XP003018055 *
WAKSMAN S.A. ET AL.: "Chaetomin, a New Antibiotic Substance Produced by Chaetomium cochliodes: I. Formation and Properties", J. BACTERIOL., vol. 48, no. 5, 1944, pages 527 - 530, XP003018056 *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8324265B2 (en) 2005-11-21 2012-12-04 Shionogi & Co., Ltd. Heterocyclic compounds having type I 11β hydroxysteroid dehydrogenase inhibitory activity
CN101754954B (en) * 2007-05-18 2015-11-25 盐野义制药株式会社 There is the nitogen-contained heterocycle derivant of 11beta-Hydroxysteroid dehydrogenase I type inhibit activities
WO2008142986A1 (en) * 2007-05-18 2008-11-27 Shionogi & Co., Ltd. NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE HAVING 11 β-HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORY ACTIVITY
US8383622B2 (en) 2007-05-18 2013-02-26 Shionogi & Co., Ltd. Nitrogen-containing heterocyclic derivative having 11β-hydroxysteroid dehydrogenase type I inhibitory activity
US8614080B2 (en) 2007-09-27 2013-12-24 Shionogi & Co., Ltd. Method for producing hydroxylated adamantane using cytochrome P450
US8383381B2 (en) 2007-09-27 2013-02-26 Shjonogi & Co., Ltd. Method for producing hydroxylated adaivjantane using cytochrome P450
WO2009041470A1 (en) * 2007-09-27 2009-04-02 Shionogi & Co., Ltd. Method for producing hydroxylated adamantane using cytochrome p450
US8507493B2 (en) 2009-04-20 2013-08-13 Abbvie Inc. Amide and amidine derivatives and uses thereof
EP2243479A2 (en) 2009-04-20 2010-10-27 Abbott Laboratories Novel amide and amidine derivates and uses thereof
WO2011078101A1 (en) 2009-12-22 2011-06-30 塩野義製薬株式会社 Adamantanamine derivative
US8796468B2 (en) 2009-12-22 2014-08-05 Shionogi & Co., Ltd. Adamantanamine derivative
US8901316B2 (en) 2010-08-09 2014-12-02 Shionogi & Co., Ltd. Process for preparing aminoadamantyl carbamate derivatives
WO2012124781A1 (en) 2011-03-17 2012-09-20 塩野義製薬株式会社 Method for producing pyrazolecarboxylic acid derivative

Also Published As

Publication number Publication date
JPWO2007114125A1 (en) 2009-08-13
TW200808970A (en) 2008-02-16

Similar Documents

Publication Publication Date Title
US11767292B2 (en) Process for making beta 3 agonists and intermediates
WO2007114125A1 (en) Process for production of hydroxylated adamantane using microorganism
US7767432B2 (en) Methods for the preparation, isolation and purification of epothilone B, and x-ray crystal structures of epothilone B
Chen et al. Epigenetic modifier-induced biosynthesis of novel fusaric acid derivatives in endophytic fungi from Datura stramonium L.
JP2004516011A (en) Fermentation process for epothilone
JP2006517934A (en) Substituted heterocycle
CN1914198A (en) Method of stabilizing macrolide compound
TWI287579B (en) Stereoselective reduction of substituted oxo-butanes
JP2013138617A (en) Method for producing 14-dehydroergosterol by microbial fermentation
Mihovilovic et al. Biooxidation of ketones with a cyclobutanone structural motif by recombinant whole-cells expressing 4-hydroxyacetophenone monooxygenase
JP2014226048A (en) Method for producing aromatic compounds
HOEHN et al. 3'-Demethoxy-3'-hydroxystaurosporine, a novel staurosporine analogue produced by a blocked mutant
US20110098477A1 (en) Method Of Producing Compound Having Anti-Hcv Activity
WO2008092950A1 (en) Fermentation process for preparing pravastatin
CA1321788C (en) Antitumor substance, process for preparing the same and anticancer agent containing the same
JP2006314248A (en) Method for producing triterpene derivative
JP6181971B2 (en) Method for producing aromatic compound
JP4836783B2 (en) Antitumor agent, method for producing antitumor agent, pharmaceutical composition containing antitumor agent, and antitumor agent-producing bacterium
JP3153959B2 (en) Compound TAN-1251, derivatives thereof, methods for their production and uses
US20230192629A1 (en) Methods of synthesizing farnesyl dibenzodiazepinones
JP2005278525A (en) Method for producing aromatic compound
JP4382038B2 (en) New physiologically active substance PF1270A, B and C substances
JP2002017386A (en) Method for producing indole-3-carboxylic acid derivative
WO2013017517A1 (en) Process for production of optically active (r)-(-)-1-(2,4-dichloro-phenyl)-2-imidazole-1-yl-ethanol
WO2005083102A1 (en) Process for producing optically active 1,4-benzodioxin-2-carboxylic acid derivative

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07739980

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2008508544

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07739980

Country of ref document: EP

Kind code of ref document: A1